|
|
||||||||
1 Department of Medical Physiology, Cardiovascular Research Institute, Texas A&M University System Health Science Center, College Station, Texas 77845; and 2 Department of Human Biology, Royal Melbourne Institute of Technology University, Bundoora, Victoria 3083, Australia
| |
ABSTRACT |
|---|
CHANNELS...
|
|---|
Ion channels are regulated by protein phosphorylation and
dephosphorylation of serine, threonine, and tyrosine residues. Evidence for the latter process, tyrosine phosphorylation, has increased substantially since this topic was last reviewed. In this review, we
present a comprehensive summary and synthesis of the literature regarding the mechanism and function of ion channel regulation by
protein tyrosine kinases and phosphatases. Coverage includes the
majority of voltage-gated, ligand-gated, and second messenger-gated channels as well as several types of channels that have not yet been
cloned, including store-operated Ca2+ channels,
nonselective cation channels, and epithelial Na+ and
Cl
channels. Additionally, we discuss the critical roles
that channel-associated scaffolding proteins may play in localizing
protein tyrosine kinases and phosphatases to the vicinity of ion channels.
receptor tyrosine kinase; nonreceptor tyrosine kinase; protein
tyrosine phosphatase; integrins; cytoskeleton; K+ channel; Ca2+ channel; Cl
channel; ligand-gated
channel; Na+ channel; receptor-activated channel; calcium
release-activated current; focal adhesion; growth factors; scaffolding
proteins; Src; Fyn; Lck; Hck; A kinase-associated protein; PDZ; SH2; SH3; CFTR; MAGUK
| |
INTRODUCTION |
|---|
CHANNELS...
|
|---|
ION CHANNELS ARE TARGETS of many
intracellular signaling pathways, including protein phosphorylation and
dephosphorylation. These processes can modify channel activity and
dramatically alter the electrophysiological properties of both
excitable and nonexcitable cells. Two well-known examples of this type
of regulation are the L-type Ca2+ channel and the large
conductance Ca2+-dependent K+
(maxi-KCa) channel, proteins that often have opposing
physiological functions (157). The L-type Ca2+
channel is the primary voltage-dependent Ca2+-influx
pathway in many excitable cells. Its pore-forming subunit,
1C, contains NH2- and COOH-terminal
cytosolic domains that are potential targets for protein
phosphorylation. For example, in cardiac myocytes, activation of
1-adrenergic receptors leads to an increase in cytosolic
cAMP, which activates the serine-threonine kinase protein kinase A
(PKA). PKA phosphorylates Ser1928 of the
1C
COOH-terminus, shifting the voltage activation of the Ca2+
channel toward more negative potentials and producing an enhancement in
whole cell L-type Ca2+ current (62). The
resulting increase in Ca2+ influx contributes to the
chronotropy and inotropy induced by sympathetic activation of the heart
(140). L-type Ca2+ current is also potentiated
by agonists of endothelin,
1-adrenergic, and angiotensin
II receptors through an effect on another serine-threonine kinase,
protein kinase C (PKC). However, the exact phosphorylation mechanisms
and sites of PKC action are unclear (106). The
maxi-KCa channel is also regulated by serine
phosphorylation. This channel is composed of pore-forming
-subunits
and a regulatory
-subunit, with the COOH-termini of the
-subunits
being cytosolic. The maxi-KCa channel is regulated by
voltage in a Ca2+-dependent manner. Protein kinase G (PKG)
phosphorylates the
-subunit at Ser1072 near the
COOH-terminus (60), shifting the Ca2+
sensitivity of the channel and producing hyperpolarization (10, 23). Other putative PKG and PKC phosphorylation sites occur on
the
-subunit COOH-terminus in splice variants of the
maxi-KCa channel, which may account for the various
phenotypes of the channel observed in different tissues
(237).
In addition to the extensive information available about the regulation of ion channels by serine-threonine kinases (for a review, see Ref. 95), an emerging body of evidence suggests that channels are also regulated by phosphorylation on tyrosine residues (for reviews, see Refs. 104, 123, 124, 215, 240). Growth factors, which act through receptor tyrosine kinases, are known to regulate the function and expression of many proteins, including ion channels (14, 178). The literature also indicates that nonreceptor tyrosine kinases can regulate ion channels. Collectively, this evidence suggests a mechanism whereby by growth factors, cell-cell, and cell-substrate interactions acutely regulate cell function through ion channels.
The purpose of this review is to summarize the current state of this field. As will become evident, the majority of voltage-gated, ligand-gated, and second messenger-gated channels are regulated to some degree by tyrosine phosphorylation. We review the evidence to support this concept for most major classes of ion channels, making extensive use of tables to summarize the literature. We examine the probable roles of signaling pathways involving receptor and nonreceptor tyrosine kinases that would be expected to lead to channel regulation. We discuss the critical roles that channel-associated scaffolding proteins may play in localizing protein tyrosine kinases and phosphatases to the vicinity of ion channels. Finally, when possible, we speculate on the physiological significance of ion channel regulation by these processes.
Glossary
| AChR | Nicotinic acetylcholine receptor |
| AKAP | A kinase-associated protein |
| AMPA | -Amino-3-hydroxy-5-methyl-4-isoxazole proprionate
|
| BDNF | Brain-derived neurotrophic factor |
| BKCa channel | Large (big) conductance KCa channel |
| bRET | Bovine rod channel |
| [Ca2+]i | Intracellular Ca2+ concentration |
| CaM | Calmodulin |
| Cav channel | Voltage-activated Ca2+ channel |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| ClC channel | Voltage-gated Cl channel family
|
| CNG channel | Cyclic nucleotide-gated channel |
| Csk | c-Src kinase |
| DEP | dsh/egl-10/pleckstrin domain |
| EGF | Epidermal growth factor |
| EGFR | EGF receptor |
| ENaC | Amiloride-sensitive Na+ channel |
| FAK | Focal adhesion kinase |
| FGF | Fibroblast growth factor |
| GABA | -Amino butyric acid
|
| GIRK channel | G protein-coupled inwardly rectifying K+ channel |
| GK | Guanylate cyclase |
| GKAP | G kinase-associated protein |
| GST | Glutathione-S-transferase |
| HEK | Human embryonic kidney (cell line) |
| ICRAC | Calcium release-activated current |
| IGF | Insulin-like growth factor |
| INAD | Inactivation-no-afterpotential D (protein) |
| Ins(1,4,5)P3 | D-myo-Inositol (1,4,5)-trisphosphate |
| JAK2 | Janus kinase 2 |
| KATP channel | ATP-sensitive K+ channel |
| KCa channel | Ca2+-dependent K+ channel |
| Kir channel | Inwardly rectifying K+ channel |
| Kv channel | Voltage-gated K+ channel |
| MAGUK | Membrane-associated GK |
| MAPK | Mitogen-activated protein kinase |
| MDCK | Madin-Darby canine kidney (cell line) |
| MuSK | Muscle-specific (tyrosine) kinase |
| NGF | Nerve growth factor |
| NGFR | NGF receptor |
| NMDA | N-methyl-D-aspartate |
| NT3 | Neurotrophin-3 |
| PC12 | Rat pheochromocytoma |
| PDGF | Platelet-derived growth factor |
| PDZ | PSD-95/SAPSO, Dlg, and 20-1 domain |
| PH | Pleckstrin homology |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PKG | Protein kinase G |
| PLC | Phospholipase C |
| Po | Open probability |
| PTB | Phosphotyrosine binding |
| PTK | Protein tyrosine kinase |
| PTP | Protein tyrosine phosphatase |
| PX | Phox homology |
| PYK2 | Pyruvate kinase 2 |
| RACC | Receptor-activated Ca2+ channel |
| RPTP | Receptor PTP |
| RVD | Regulatory volume decrease |
| rOLF channel | Rat olfactory CNG channel |
| RPTP | Receptor PTP |
| SERCA | Sarco(endo)plasmic reticulum Ca2+-ATPase |
| SH2 | Src homology 2 |
| SH3 | Src homology 3 |
| Src | Sarcoma virus tyrosine kinase |
| STOC | Spontaneous transient outward current |
| Trp | Transient receptor potential |
| TTX | Tetrodotoxin |
| VEGF | Vascular endothelial growth factor |
| |
RECEPTOR AND NONRECEPTOR TYROSINE KINASES |
|---|
CHANNELS...
|
|---|
To provide a context for understanding how ion channels are regulated by tyrosine phosphorylation, some brief discussion of PTKs and phosphatases seems appropriate.
PTKs were initially discovered as the products of oncogenes from transforming retroviruses (91). PTKs are responsible for transducing key extracellular signals that mediate events such as proliferation, cytoskeletal rearrangement, and coordination of physiological responses. Cellular PTKs can be divided into two primary groups: receptor and nonreceptor PTKs (117).
Members of the receptor PTK family include the insulin receptor and growth factor receptors such as EGF, PDGF, FGF, IGF, and VEGF receptors. Structurally, the receptor PTKs are characterized by an extracellular ligand-binding domain, a transmembrane domain, a kinase-catalytic domain, and cytoplasmic regions responsible for organizing signaling molecules. Signal transduction is initiated by a sequence of growth factor (ligand) binding to the extracellular domain, dimerization of the receptor proteins, and autophosphorylation of the receptor. Receptor autophosphorylation creates phosphorylated tyrosine residues on the cytoplasmic tail of the receptor. These phosphorylated tyrosine residues form docking sites for signaling molecules, and it is the combination of these signaling molecules that determines the specificity of individual receptor PTKs (51).
Nonreceptor PTKs are found in both the cytoplasm and nuclei of cells. The largest family of cytoplasmic PTKs is the Src family (for a review, see Ref. 1). The Src family consists of eight members: Src, Fyn, and Yes (which are ubiquitously expressed) and Lck, Hck, Fgr, Lyn, and Blk (which exhibit a more restricted expression pattern). Src family PTKs are characterized by NH2-terminal sequences that direct myristolation or pamitoylation, resulting in membrane localization. Other sequences include a nonconserved unique domain, an SH3 domain that directs binding to polyproline-rich sequences, an SH2 domain that binds phosphotyrosine, a catalytic domain, and a short COOH-terminal tail. Regulation of Src family members is highly conserved. In particular, there are two tyrosine residues: one in the kinase domain and one in the COOH-terminal tail, whose phosphorylation state is important for Src activation. Autophosphorylation of the kinase domain tyrosine leads to increased kinase activity, whereas phosphorylation of the COOH-terminal tail region by Csk represses activity (164). Hence, activation can occur by dephosphorylation of the COOH-terminal tyrosine by a phosphatase such as RPTP or phosphorylation of the kinase domain tyrosine (69). Many stimuli, including receptor PTKs, G protein-coupled receptors, and integrins, have been implicated in Src activation, making this family of kinases a key point of integration for many signal transduction pathways. It is now clear that autophosphorylation of receptor PTKs can form binding sites on the receptor for Src family members and that these nonreceptor PTKs are important for some of the downstream signaling events initiated by receptor binding (233).
The other class of nonreceptor PTKs that is important for this discussion includes FAK and Pyk2/RAFTK (for a review, see Ref. 12). pp125FAK is a 125-kDa PTK that is discretely localized to cellular focal adhesions and has been shown to colocalize with integrins. FAK is a major substrate for integrin-dependent tyrosine phosphorylation, and, upon phosphorylation, it becomes enzymatically active and serves as a scaffold for the binding and localization of other proteins to the focal adhesion (201). Pyk2/RAFTK is characterized by a more diffuse cytoplasmic localization and can be activated by stress signals (122) and by a variety of extracellular signals that elevate [Ca2+]i. FAK and Pyk2/RAFTK exhibit ~48% amino acid identity and have a similar organization: a unique NH2-terminal region, a centrally located PTK domain, and two proline-rich regions at the COOH-terminus. Neither kinase contains SH2 or SH3 domains.
Activation of the Src family members FAK and Pyk2/RAFTK serves as a central integration mechanism for a number of extracellular signaling pathways. For example, when integrins on the cell surface are engaged, signal transduction pathways are triggered. Because integrins lack intrinsic enzymatic activity, they rely on the activation of a number of cytoplasmic signaling molecules, including FAK and Src. The two proteins are colocalized, and their interaction leads to autophosphorylation of FAK, creation of a binding site for the Src SH2 domain, and ultimately to Src activation (198). Src then serves to phosphorylate additional sites on FAK, allowing binding of other signaling molecules and scaffolding proteins (179, 200). This process leads to the assembly of complex signaling molecules at the focal adhesion site and organizes signaling events further downstream. There is increasing evidence for synergy between receptor PTKs and integrin signaling pathways. The Src-FAK pathways are thought to be key sites for the integration of signals from integrin pathways (203), and evidence for this integration with respect to ion channel regulation will be apparent in subsequent sections of this review.
PTPs are composed of two groups: one that recognizes phosphoserine, phosphothreonine, and phosphotyrosine residues and another that specifically recognizes phosphotyrosines (174, 249). The latter group can be subdivided into intracellular (nonreceptor) or receptor PTPs. PTPs have a conserved catalytic domain that recognizes the VIHCSAGXGRXG motif. Receptor PTPs contain extracellular domains with structural motifs similar to those found in cell adhesion molecules and two catalytic domains on their intracellular COOH-terminus. Nonreceptor PTPs contain only a single conserved phosphatase domain flanked by noncatalytic segments that mediate interactions with adapter molecules through specific protein-protein interaction domains (see THE CHANNEL-PROTEIN KINASE REGULATORY COMPLEX). Although much is known about the structure and function of PTPs (174), the evidence for involvement of specific PTPs in the regulation of ion channels is sparse.
| |
TYPES OF SUPPORTING EVIDENCE |
|---|
CHANNELS...
|
|---|
Initial evidence that ion channels were regulated by tyrosine phosphorylation came largely from pharmacological studies using soluble inhibitors of PTKs. Electrophysiological and molecular biology methods have subsequently provided insight into the mechanisms of channel regulation. This progression of methodology can be traced using the L-type Ca2+ channel as an example and is detailed below.
In vascular smooth muscle, broad-spectrum PTK inhibitors such as genistein and herbimycin attenuate depolarization-induced tone (64, 236) as well as myogenic tone (135, 165). Genistein inhibits the rise in [Ca2+]i induced by KCl depolarization (64), suggesting that it acts on a Ca2+ entry mechanism. Electrophysiological studies confirm that soluble PTK inhibitors block whole cell Ca2+ current (265), including studies that utilize inhibitors such as PP1 and PP2, which more specifically target certain PTKs, e.g., Src (48, 270). Other studies have employed strategies involving intracellular dialysis with antibodies or peptides directed at specific kinases. For example, L-type Ca2+ current in smooth muscle is increased by intracellular dialysis with a pipette solution containing a c-Src-activating peptide (263) or constitutively active Src (270) but is inhibited by monoclonal antibodies against c-Src (84, 270). Studies combining electrophysiological and molecular biology strategies have provided the best evidence for specific channel-kinase interactions. Expression of recombinant L-type Ca2+ channels in a mammalian cell line, along with kinase-dead Src to compete with endogenous Src, results in blockade of the otherwise potentiating action of IGF-1 on Ca2+ current (16). Subsequently, these electrophysiological data have been supported by biochemical evidence for Src-Ca2+ channel association using immunoprecipitation and GST fusion protein assays (16, 84). In addition, kinase assays show that purified Src kinase can phosphorylate L-type Ca2+ channels in vitro (16). Collectively, this combination of methods provides convincing support for the idea that the L-type Ca2+ channel is regulated by tyrosine phosphorylation.
As noted in our data tables, the majority of evidence for regulation of ion channels by tyrosine phosphorylation is based primarily on the effects of soluble PTK inhibitors. A major flaw in this evidence is that these antagonists are reported to have nonspecific effects (3), including direct interactions with channels (85, 166, 216), inhibition of serine-threonine kinases (2), interactions with Ca2+ indicators (17), and other nonkinase actions (114, 278). Thus approaches that depend solely on the use of these inhibitors must be interpreted with caution. A stronger case for regulation by tyrosine phosphorylation can be made if multiple PTK inhibitors acting through different mechanisms produce the same effect on a channel or if structurally related inactive forms are used. However, because some soluble PTK inhibitors are relatively specific for certain kinase families (e.g., herbimycin A, PP1, and PP2), the lack of an effect on a given channel may simply indicate that a certain class of PTK is not involved in regulation of that channel. Ideally, supportive evidence would be provided by an opposite effect resulting from inhibition of PTPs. Unfortunately, few selective tools are available to selectively inhibit PTPs. The most commonly used phosphatase blockers, pervanadate and sodium orthovanadate, are also inhibitory for serine-threonine phosphatases (72). The purification and use of specific PTPs and their inhibitors will obviously allow more specific testing of the role of these enzymes in ion channel regulation.
Although molecular approaches can potentially be used to pinpoint the site and mechanism of action of a specific PTK, these approaches are not without their own limitations. Expression of specific channel subunits in Xenopus oocytes or in mammalian cell systems (e.g., HEK 293 and COS-7) can result in uncertainties about proper membrane targeting of the channel. In many cases, the complete array of functions for accessory subunits are unknown, so that it cannot be determined a priori which channel subunits need to be expressed. Some expression systems may not possess the adequate intracellular signaling machinery to reconstitute a specific PTK-ion channel regulatory pathway. Also, some channels may undergo posttranslational processing in native cells to alter associations between channel subunits (63), but this processing may not be possible in recombinant expression systems due to lack of the appropriate enzymatic machinery. These inherent difficulties can lead to substantial differences in the behavior and regulation of expressed versus endogenous channels. Therefore, it is necessary to keep these limitations in mind when interpreting such studies, and the conclusions must ultimately be confirmed using the endogenous channel and PTK(s) in the native cell system.
| |
REGULATION OF LIGAND-GATED CHANNELS BY PTKS |
|---|
CHANNELS...
|
|---|
Ligand-gated ion channels are among the most precisely localized
of membrane proteins through their extensive associations with specific
scaffolding and cytoskeletal proteins at the postsynaptic density
(207, 208). PTKs are also highly localized in this region (227). It is therefore not surprising that several types
of ligand-gated channels are associated with, and/or regulated by,
PTKs. We will review the evidence for regulation of three distinct
types of ligand-gated channels by tyrosine phosphorylation. Other
ligand-gated channels, or their scaffolding protein partners, are also
known to be associated with PTKs (25), e.g., the AMPA
receptor is associated with the nonreceptor PTK Lyn (71).
However, this section will focus on those channels for which there is
the best functional evidence for this type of regulation (see Table
1).
|
AChR
AChR is a neurotransmitter-gated ion channel that mediates the response to acetylcholine at the postsynaptic membrane of nicotinic cholinergic synapses. This receptor was one of the earliest and best-characterized ligand-gated channels due to the capability of isolating large quantities from Torpedo californica. AChR is composed of a pentameric rosette of four different membrane-spanning subunits, with the stoichiometry
2

. Each
-subunit binds acetylcholine and is regulated by a number of
serine-threonine kinases, including PKA and PKC (89). As
early as 1984, it was demonstrated that AChR could be tyrosine
phosphorylated by an endogenous PTK (90). The
-,
-,
and
-subunits each contain a single tyrosine phosphorylation site on
the major intracellular loop between transmembrane domains three and
four. Tyrosine phosphorylation of one or more subunits increases the
rate of channel desensitization (81).
Regulation of AChR localization is coordinated by a number of accessory
proteins through tyrosine phosphorylation events. During
synaptogenesis, the neurally released factor agrin causes the
clustering of AChRs. Agrin is an extracellular heparin sulfate proteoglycan capable of binding growth factors (36) and,
along with at least one accessory protein, stimulates the
muscle-specific receptor PTK MuSK. The
-subunit of AChR is tyrosine
phosphorylated by MuSK or by an intermediate PTK, perhaps Fyn or Src
(59), through a process involving one or more scaffolding
proteins, including rapsyn (36). The
- and
-subunits
of AChR are also tyrosine phosphorylated (89). Fyn and Fyk
PTKs are known to associate through their SH2 domains with the YFNI
sequence of the
-subunit (228). Of note, tyrosine
phosphorylation of the
-subunit results in its association with the
adaptor protein Grb2 in the AChR complex (35). Grb2 is a
key upstream player in the Ras-MAPK signaling pathway, leaving open the
possibility that this pathway regulates the channel. However, the
extent to which these accessory proteins and PTKs play a role in
functional regulation of AChR, e.g., channel sensitization or
desensitization, is not known.
NMDA Receptor
NMDA receptors are a class of glutamate receptor, the major excitatory neurotransmitter receptor in the central nervous system. NMDA receptors are composed of NR1 and NR2 subunits arranged, presumably, in a tetramer. NR1 has only a short cytoplasmic tail, but its interaction with
-actinin and CaM
is necessary for Ca2+-dependent inactivation of the
receptor (272). Each NR2(A-D) subunit has
a long COOH-terminal cytoplasmic tail, at the end of which is a
conserved sequence that mediates binding to the first two PDZ domains
of the synaptic scaffolding protein PSD-95. This interaction appears to
be important for regulation by kinases. Physiological properties of the
NMDA receptor are modulated by the serine-threonine kinase PKC,
although the role of subunit phosphorylation in this process is
controversial (279). However, NR2A and
NR2B subunits can be tyrosine phosphorylated
(115), particularly NR2B (151).
NR2 subunits also coimmunoprecipitate with several Src
family kinases, including Src, Fyn, Yes, and Lyn (115, 232,
275). Fyn binds through its SH2 domain to the third PDZ domain
of PSD-95, and Fyn-deficient mice show greatly reduced levels of
NR2 phosphorylation. Heterologously expressed NMDA receptor
subunits can also be phosphorylated by Src and Fyn (112,
232).
NMDA receptor currents are potentiated by PTK activation and inhibited by PTP activation (112, 253). For example, the Src-activating peptide EPQ(pY)EEIPIA applied to the intracellular surface of the NMDA receptor increases Po of the native channel in cultured neurons from the rat spinal dorsal horn (128). Another peptide containing the amino acid sequence 40-58 of Src blocks the action of EPQ(pY)EEIPIA. Po is reduced by either of two Src antibodies but increased by recombinant pp60c-Src (128, 253). Importantly, the effects of these peptides are also evident on the NMDA component of miniature excitatory postsynaptic currents (128). Further evidence for a physiological effect is the correlation between enhanced tyrosine phosphorylation of NMDA receptors and long-term potentiation (191, 192). Src and Fyn kinases lose their potentiating effect on recombinant NR1-NR2A channels if the COOH-terminus of NR2A is deleted (112). Coimmunoprecipitation of NR2 subunits and Src family kinases suggests a physical association between the receptor and the kinase (115), although intermediate kinase(s) may also be involved. Indeed, the inhibitory action of Src(40-58) peptide, which does not itself interact with the Src catalytic domain (128), points to additional protein-protein interactions required for tyrosine phosphorylation of the receptor.
GABA Receptor
GABA receptors are ligand-gated Cl
channels
concentrated in the postsynaptic membrane of GABAergic synapses. The
GABA receptor is a heteropentameric protein assembled from
-,
-,
-,
-, and
-subunits (250). Each subunit consists
of a 40- to 60-kDa polypeptide with four transmembrane regions and an
extracellular COOH-terminus. Regulation of channel subunits by
phosphorylation occurs at multiple sites on an intracellular loop
between transmembrane segments three and four (29).
Initial studies indicated that the GABAA receptor, the most
widely distributed subunit, is modulated by tyrosine phosphorylation of
the
2- and
1-subunits. GABAA
receptors expressed in oocytes are inhibited by genistein and
tyrphostin B-44, and this effect is associated with tyrosine
phosphorylation of
2- and
1-subunits by
the nonreceptor PTK pp60c-Src (243). If
1-,
1-, and
2-subunits are
expressed in HEK 293 cells along with a constitutively active form of
Src, v-Src, two tyrosine residues on
2 are
phosphorylated and whole cell GABA current is enhanced
(154). Mutation of residues Tyr365/367 to
Phe365/367 on
2 blocks Src-induced
phosphorylation and enhancement of current. Mutation of residues
Tyr384/386 to Phe384/386 on
1
blocks Src-induced phosphorylation without any obvious effect on
current, suggesting that tyrosine phosphorylation of
2
is critical to regulation (154). The function of
1 tyrosine phosphorylation remains to be determined. In
superior cervical ganglion neurons, native GABAA channels
are modulated by tyrosine kinase/phosphatase inhibitors and by dialysis
with c-Src in a way consistent with physiological potentiation of
GABAA current by tyrosine phosphorylation
(154).
A similar regulation of GABAA is observed in spinal dorsal
horn neurons. GABAA currents are reversibly inhibited by
genistein but potentiated by recombinant pp60c-Src
(250). Both
2/
3-subunits are
tyrosine phosphorylated by an endogenous PTK(s); however,
genistein appears to produce comparable inhibition of GABA current in
heterologously expressed
1
2-subunits compared with
1
2
2-subunits. This
suggests that
2, not
2, is required for
this regulation (250). The functional significance of
2 tyrosine phosphorylation is not yet known.
In contrast, tyrosine phosphorylation of frog melanotroph
2/
3-subunits inhibits GABA-evoked current
(29). Soluble PTK inhibitors potentiate GABA currents
in inside-out patches from these cells and reduce endogenous
phosphorylation of
2/
3-subunits. Furthermore, single channel currents are inhibited by recombinant pp60c-Src or the PTP inhibitor sodium orthovanadate. The
reasons for these disparate results (29, 250) are unknown,
but they possibly reflect the actions of multiple interacting tyrosine
phosphorylation events, different endogenous PTKs, phosphorylation of
different GABA subunits, or involvement of different channel-associated scaffolding proteins.
| |
REGULATION OF K+ CHANNELS BY PTKS |
|---|
CHANNELS...
|
|---|
Kv Channels
Kv channels are composed of tetramers of transmembrane
-subunits associated with up to four
-subunits. There are over a dozen distinct Kv
-subunit genes and at least three Kv
-subunit genes with multiple alternative splice variants (43).
Differential assembly and association of
- and
-subunits into
homo- and heterotetramers confer functional diversity to the channel.
There are four main Kv subfamilies: Shaker (Kv1), Shab (Kv2), Shaw
(Kv3), and Shal (Kv4). In each family, the
-subunit contains six
membrane-spanning helices (S1-6) and a highly conserved short P
loop between S5 and S6 that forms the channel conduction pathway
(97). S4 is the presumed voltage sensor. S1 and S6 contain
the cytosolic sequences corresponding to the NH2- and
COOH-termini, respectively (42). The
NH2-terminal region of S1 (130 residues) is known as the T1 domain and is the site of protein-protein interactions. Kv channel
-subunits are intracellular proteins that play a critical role in
membrane targeting of the channel and possibly confer functional properties, e.g., causing fast inactivation of the intrinsically slow
inactivating
-subunit (101).
Initial evidence for Kv channel regulation by tyrosine phosphorylation
was based on the effects of pharmacological inhibitors of tyrosine
kinases and phosphatases. The evidence was obtained using a variety of
native cells as well as recombinant channels in heterologous expression
systems. The majority of these studies are summarized in Table
2. Our discussion
focuses primarily on combined electrophysiological and molecular
biology studies that provide the most compelling evidence.
|
Regulation of Shaker family Kv channels by tyrosine phosphorylation is
firmly established. Coexpression of the M1 (muscarinic) AChR and the delayed rectifier K+ channel, Kv1.2, in
oocytes results in suppression of K+ current after
activation of the receptor (87). This inhibition is
mediated by tyrosine phosphorylation of the channel subsequent to
activation of PLC-
1 and PKC. Suppression of Kv current is relieved
by mutation of a single tyrosine residue, Tyr132 to
Phe132, on the NH2-terminus of the channel.
This mutation reduces both basal and carbachol-induced tyrosine
phosphorylation of the channel, as assessed from immunoprecipitation
protocols. In contrast, mutation of another NH2-terminus
site, Tyr76 to Phe76, or two potential serine
phosphorylation sites for MAPK on the COOH-terminus have no effect on
the inhibition caused by muscarinic agonists (87).
Coexpression of M1 AChR, Kv1.2, and EGFR in HEK 293 cells results in suppression of K+ current after receptor activation (87, 239). Application of EGF alone results in suppression of Kv1.2 current and phosphorylation of Kv1.2 by EGFR, but the "specific" EGFR kinase inhibitor tyrphostin AG1478 blocks carbachol-mediated inhibition of Kv1.2 current (239). Therefore, M1 AChR appears to transactivate EGFR to modulate the K+ channel. Because AG1478 blocks only ~50% of this response, it leaves open the possibility that other PTKs may also be involved. Indeed, in PC12 cells, another PTK responsible for phosphorylation of Kv1.2 is the nonreceptor tyrosine kinase PYK2 (122). PYK2 activity is stimulated by depolarization, by PKC, and by agonists of G protein-coupled receptors (e.g., bradykinin), all of which stimulate increases in [Ca2+]i and subsequently inhibit Kv1.2 current (122).
In T lymphocytes, Kv1.3 is tyrosine phosphorylated after stimulation of Fas (an apoptosis-related protein), which leads to apoptotic cell death. Phosphorylation appears to be mediated by the tyrosine kinase p56Lck because deficiency in that kinase abolishes inhibition of current by Fas, whereas reconstitution of p56Lck restores the effect (229). Whether Lck interacts directly with the channel has not been determined. When Kv1.3 is coexpressed in HEK 293 cells with EGFR or v-Src, the channel becomes tyrosine phosphorylated and current is suppressed by >95% (24, 78). PTK inhibitors relieve the current suppression by v-Src. The action of v-Src is not mediated by an effect on Kv1.3 expression but by modulation of channel activation and inactivation kinetics (78). On the basis of mutational analysis, regulation of Kv1.3 kinetics by Src is determined by multiple interacting phosphorylation sites, including Tyr137 on the Kv1.3 NH2-terminus and Tyr449 on the COOH-terminus (24). Interestingly, inhibition of Kv1.3 by EGF, which is predominantly through speeding of C-type inactivation, is mediated at a different site, Tyr479. Collectively, these observations imply that Kv1.3 can be differentially regulated by various PTKs.
The NH2-terminus of the human K+ channel, hKv1.5, contains a proline-rich SH3 domain known to interact with Src (79). The channel and enzyme colocalize in cell adhesion zones in the myocardium (138). Coexpression of Src and hKv1.5 in HEK 293 cells results in tyrosine phosphorylation of the channel and suppression of channel current (79). This is consistent with inhibition of Kv current by EGF in cardiac myocytes (24).
In contrast to the recombinant K+ channel studies cited
above, tyrosine phosphorylation of native Kv current in mouse Schwann cells leads to current activation (219). This action is
apparently mediated by the Src-family kinase p55Fyn because
cell dialysis with recombinant Fyn kinase results in potentiation of a
slowly inactivating K+ current component that is blocked by
herbimycin A. Both Kv1.5 and Kv2.1
-subunits are constitutively
tyrosine phosphorylated (219). Furthermore,
coimmunoprecipitation and double-labeling experiments suggest a direct
association between the p55Fyn and K+ channels
in these cells (219). Kv2.1 associates with Fyn through an
SH2 domain (219), in contrast to Kv1.5, which associates
with Src family kinases through its SH3 domain (79). The
effect of tyrosine phosphorylation on K+ current in this
study is noteworthy because nearly all other Kv channel studies suggest
that the end result of tyrosine phosphorylation is inactivation of the
channel. Sobko et al. (219) proposed that this discrepancy
may be related to the absence of regulatory channel subunits in some
heterologous expression systems or to the possibility that
heteromultimers formed with Kv2.1 subunits in native cells confer this
type of regulation by PTKs (219). In support of this idea,
at least two other studies presented indirect evidence for activation
of native K+ current after stimulation of receptor PTKs
(104, 173, 181). It is also possible that multiple
receptor and nonreceptor PTKs are involved in the normal regulation of
Kv channels, e.g., Src (49, 77, 125), EGFR
(239), PYK2 (122), and JAK2
(181). Resolution of these important issues may completely
alter conclusions about the physiological role of Kv channel tyrosine phosphorylation.
Kir Channels
Structurally, Kir channels are composed of four
-subunits, each
containing the S1-S6 K+ channel pore region. These subunits
are lined by two transmembrane segments with intracellular
NH2- and COOH-termini (194). Kir tetramers
show varying degrees of inward rectification, as assessed by the
current-voltage relationship of the channel. Kir1.x (ROMK) channels
control K+ secretion in epithelium. Kir3.x (GIRK) channels
are regulated by heterotrimeric G proteins. Kir6.x channels form
octomers with sulphonylurea receptors to compose channels
(KATP channels) that are regulated by intracellular ATP/ADP
in a variety of tissues, notably pancreatic
-cells. Several Kir
family members are regulated by PKA and PKC in different ways and with
different effects. For example, PKA-dependent phosphorylation inhibits
Kir2.1 but modulates pH sensitivity in Kir1.1 (194).
Kir channels are also regulated by tyrosine phosphorylation, as summarized in Table 2. Native and recombinant Kir2.1 currents are suppressed by perorthovanadate inhibition of PTPs, and inhibition is reversed by genistein (268). Both effects are prevented by mutation of Tyr242 to Phe242 in the Kir2.1 COOH-terminus (268). When Kir2.1 is coexpressed with NGFR or EGFR, application of the appropriate ligand leads to suppression of current. Other growth factors (NT3 or BDNF) similarly suppress current, either by crossreaction with NGFR or by interaction with endogenously expressed receptor PTKs (268). Additional potential tyrosine phosphorylation sites have been identified on Kir2.1 (171), but their role in regulating the channel is not known. Tyr242 is present in other members of Kir2 at the equivalent position, so receptor PTKs have the potential to regulate other Kir2 channels by this mechanism. The equivalent tyrosine site is not found in GIRK channels (Kir3.x subfamily), but mutation of either of two other tyrosine residues in Kir3.1 (Tyr12 or Tyr67) or in Kir3.4 (Tyr32 or Tyr53) blocks BDNF-induced inhibition of current (189). The sites more proximal to the NH2-terminus appear to play the more critical role in regulating the BDNF effect. Kir3.2 channels, which lack a tyrosine residue at this site, acquire BDNF sensitivity if an Asp41 to Tyr41 mutation is made in the proximal position (189). To achieve this effect, it is also necessary to add an additional basic charge near this site, apparently to complete the general motif characteristic of PTK phosphorylation sites, i.e., charged amino acids on the NH2 side of the tyrosine and a hydrophobic residue on the COOH side (220). The specific PTK involved in regulation of Kv3.x is not known, although Kv3.1 and Src do not coimmunoprecipitate (275).
Maxi-KCa Channels
Maxi-KCa (slo) channels comprise another K+ channel family. Each channel is composed of
- and
-subunits, with the
-subunit sharing sequence homology with Kv
channel regions S1-S6. Although they are gated by voltage,
maxi-KCa (BKCa) channels possess an additional
transmembrane (S0) region that renders the NH2-terminus extracellular (237). Interaction of the
NH2-terminus with the transmembrane maxi-KCa
-subunits confers [Ca2+]i sensitivity to
the channel. The maxi-KCa COOH-terminus may be
substantially longer than that in Kv channels and is the predicted site
for protein phosphorylation (237).
Maxi-KCa is also regulated by tyrosine phosphorylation
(Table 2). In smooth muscle, STOCs, which reflect the activity of maxi-KCa channels in that cell type, are activated by EGF
and inhibited by genistein (70). In neurons, NT3 and NGF
activate paxilline-sensitive BKCa channels
(76). When the pore-forming
-subunit of the
BKCa channel, mSlo (the mammalian homologue of slo), is
coexpressed with c-Src in HEK 293 cells, the channel undergoes tyrosine
phosphorylation (125). Src has no effect on channel gating
in the absence of Ca2+, but at free cytosolic
Ca2+ levels >4 µM, channel Po is
higher at any given voltage when active Src is coexpressed. In
contrast, expression of kinase-dead Src prevents tyrosine
phosphorylation of the channel and the enhancement in Ca2+
sensitivity (125). The site of regulation appears to be
Tyr766 on the COOH-terminus because a
Tyr766 to Phe766 mutation prevents
phosphorylation of the channel by Src and the subsequent shift in
Ca2+ sensitivity (125). These experimental
approaches show convincingly that Src is required for tyrosine
phosphorylation of the maxi-KCa channel but, as with other
studies, it is not certain if the channel is directly phosphorylated by
Src or by an intermediate PTK.
| |
REGULATION OF CA2+ CHANNELS BY PTK |
|---|
CHANNELS...
|
|---|
Voltage-gated Ca2+ channels are composed of
1 (190-250 kDa)-,
2
(125 kDa)-,
and
(52-62 kDa)-subunits (47). The
1-subunit forms the voltage-gated
Ca2+-selective pore, with some 2,000 amino acids organized
in four homologous domains. Each domain contains six transmembrane
segments with a membrane reentrant pore loop in each segment
(141). Members of the dihydropyridine class of
Ca2+ antagonists interact with the
1-subunit
(224).
and
2
channel subunits
increase functional expression and therefore are likely to play roles
in membrane targeting of the channel complex. These subunits also
acutely modulate channel function. The
-subunit is cytoplasmic and
contains a highly conserved domain that interacts with the I-II loop of
1. The
-subunit is an integral membrane protein,
whereas
2 is an extracellular glycolsylated protein (106). A
-subunit (25 kDa) is found in some tissues,
notably skeletal muscle, but its function is uncertain.
At each end of the
1 channel protein are large cytosolic
NH2-terminal and COOH-terminal domains that are potential
targets for protein phosphorylation. In cardiac and brain isoforms,
1C undergoes posttranslational proteolytic processing,
after which a 30- to 50-kDa fragment of the COOH-terminus becomes
colocalized with the body (190 kDa) of the
1C- and
-subunits (63). The COOH-terminus is involved in CaM
binding and Ca2+-dependent inactivation.
Ser1928 near the COOH-terminus is a major site of
PKA-mediated phosphorylation (38). The mechanism of
regulation of
1C by PKC is still unclear (106) but requires the NH2-terminus
(212). However, when recombinant channels are expressed in
HEK 293 cells, phosphorylation of Thr27 and
Thr31 by PKC results in inhibition (not activation, as
might be expected) of current (141). Because the
NH2- and COOH-terminal domains may constitutively serve as
partially independent but interacting inhibitory gates
(212), it is possible that PKC and other kinases, including PTKs, act by relieving this inhibition.
Several lines of evidence link PTKs to the regulation of the
pore-forming subunits of voltage-gated calcium channels, including
1C (132),
1D
(222), and
1E (11).
Much of this work is summarized in Table
3.
|
At least two isoforms of the L-type Ca2+ channel are
regulated by tyrosine phosphorylation. In vascular myocytes,
Ca2+ current (
1C-b, Cav1.2b) is reduced by
PTK inhibition (127, 260), whereas PTP inhibition
increases current (264). PDGF, which stimulates tyrosine
phosphorylation of multiple proteins, enhances L-type Ca2+
current (84, 261). A key role for Src kinase in this
process is supported by observations that Ca2+ current is
1) increased by intracellular application of constitutively active Src kinase (262), 2) increased by
c-Src-activating peptide (263), and 3)
inhibited by a monoclonal antibody for c-Src (84). In
visceral smooth muscle, PDGF potentiates L-type Ca2+
current and increases tyrosine phosphorylation of
1C
(84). Additionally,
1C coimmunoprecipitates
with c-Src, and PDGF regulation of current is inhibited by dialysis
with antibodies to FAK or Src (84).
Cav1.2b is also regulated by at least three integrins. Whole cell
recordings from single arteriolar myocytes show that soluble (nonclustering) ligands of
v
3-integrin, such as RGD
peptides, inhibit L-type Ca2+ current (271).
Interestingly, bound ligands of
v
3-integrin, which
lead to integrin clustering (146), produce a similar
inhibitory effect (271). In contrast, soluble ligands of
the laminin receptor,
4
1, enhance current
(248), whereas only clustered
5
1-integrin ligands enhance current
(271). Therefore, regulation of this channel in smooth
muscle occurs by multiple intracellular pathways downstream from
v
3-,
5
1-, and
4
1-integrins, and at least two of these
pathways do not appear to require integrin clustering. As for
PDGF-potentiated currents, targeting of FAK or Src in these vascular
smooth muscle cells with specific antibodies blocks potentiation of
current by
5
1-integrin ligands
(270). Antibodies to two integrin-associated cytoskeletal
protein targets, paxillin and vinculin, also block regulation of L-type
Ca2+ current by
5
1
ligands. The ability of vinculin and paxillin antibodies to do
this is likely due to their interference with the assembly of Src or
another PTK on an intracellular scaffold of focal adhesion proteins
rather than a direct interaction with the channel. SH2 and SH3 domains
in these proteins enable them to associate with PTKs
(247). As mentioned above, the COOH-terminus of Cav1.2b
contains a proline-rich domain that has been identified as a mediator
of membrane association. This region interacts with SH3 domains in Src,
Lyn, and Hck tyrosine kinases (63), and its deletion
results in increased channel current, suggesting that it is
constitutively involved in channel inhibition (258). It is
not yet known whether phosphorylation of the
1C
COOH-terminus by any of these PTKs alters this inhibitory property.
Depolarization recruits the neuronal L-type Ca2+ channel (Cav1.2c) and results in increased tyrosine phosphorylation of multiple cytoplasmic proteins, including FAK and vinculin. PP1 blocks calcium influx through the channel and reduces phosphorylation of these proteins. Conversely, the phosphatase inhibitor sodium orthovanadate mimics the depolarization effect and recruits the channel (48). In molluscan neurons, NGF acutely enhances high voltage-activated Ca2+ currents (266). Interestingly, the extracellular matrix protein fibronectin produces a similar effect and, in addition, enhances the frequency of action potential firing (W. Wildering, personal communication). Collectively, these observations suggest that Cav1.2c is functionally regulated by tyrosine phosphorylation.
Definitive evidence for regulation of Cav1.2c by the growth
factor IGF-1, through Src, was recently presented. In cerebellar granule neurons,
1C is tyrosine phosphorylated in
response to IGF-1, resulting in potentiation of L-type Ca2+
current (21, 204). This effect can be duplicated in
recombinant
1C-c channels expressed in SH-SY5Y cells.
Potentiation occurs primarily as a result of increasing the rate of
activation at hyperpolarized potentials and likely reflects altered
gating of the
1-subunit. c-Src mediates this response
because expression of kinase-dead Src, or application of the soluble
Src inhibitor PP2, blocks potentiation of current (16).
Kinase assays using lysates from neuroblastoma cells expressing
1C-c show that purified Src kinase phosphorylates
Tyr2122 of the
1C-c COOH-terminus.
Furthermore, point mutation of Tyr2122 to
Phe2122 (but not of a nearby Tyr residue) prevents tyrosine
phosphorylation and prevents IGF-1 potentiation of current
(16). Because Cav1.2b and Cav1.2c share identical
sequences in this region, it is likely that Tyr2122
[rather than other postulated sites (84, 111)] also
mediates PDGF potentiation of current in smooth muscle. In addition to this tyrosine phosphorylation site, the intracellular loop of
1C contains two SH3 domains that may be involved in
docking of Src. Upstream of Tyr2122 are several amino acid
residues that correspond to known sequences of Src substrates, but the
various docking, adaptor, or scaffolding proteins that may be required
for tyrosine phosphorylation of this channel are not yet known.
T-type Ca2+ current in spermatogenic cells is potentiated by 50% after strong depolarization (e.g., a prepulse to +60 mV) or high-frequency stimulation (11). Unlike voltage-dependent potentiation of current in other Ca2+ channel types, the phenomenon in this tissue is not consistent with a Ca2+- or G protein-mediated mechanism. The same degree of potentiation is produced by PTK inhibitors, whereas PTP inhibitors block prepulse potentiation of current (11). Therefore, tyrosine phosphorylation/dephosphorylation may play a role in acute modulation of this channel.
| |
REGULATION OF NA+ CHANNELS BY PTKS |
|---|
CHANNELS...
|
|---|
Evidence for the regulation of two major classes of
Na+ channels, voltage-gated and epithelial Na+
channels, is summarized in Table 4.
|
Voltage-Gated Na+ Channels
Voltage-gated Na+ (VGNa) channels are composed of three subunits: a large pore-forming
-subunit and two smaller
-subunits,
1 and
2. The
-subunit is
similar in structure to that of the voltage-gated Ca2+
channel, with four homologous domains, each containing six
transmembrane segments. The extracellular domains of the
-subunits
form Ig folds with substantial homology to the neural cell adhesion
protein contactin (96) and may therefore play an important
role in channel expression and localization. The Na+
channel
-subunit is negatively regulated by PKA phosphorylation on
Ser573 of the intracellular loop linking domains I and II
(28). The
-subunit is also regulated by PKC (184,
217). However, only a few studies have examined the possible
direct modulation of Na+ channels by phosphorylation on
tyrosine residues (Table 4).
In the rat PC12 neuronal cell line, the growth factors NGF, PDGF, EGF, and basic FGF acutely inhibit VGNa (75). Inhibition is achieved through a leftward shift of the Na+ channel inactivation curve, rendering the channel more inactivated at physiological potentials. Inhibition depends on tyrosine kinase activity of the associated growth factor receptors because the receptor PTK inhibitors tyrphostin AG9 and tyrphostin AG879 almost completely reverse this effect. Furthermore, the inhibition of Na+ current by NGF and PDGF is not additive, suggesting a common signaling pathway (but this conclusion may also depend on whether maximal doses of the growth factors were used). Although the specific PTKs involved have not been determined, the Src inhibitor PP1 decreases the response to PDGF in wild-type cells, and PDGF receptors with mutations in their Src-binding domains are less effective in mediating the PDGF response (75).
A recent study of neuronal Na+ channels is one of the few
to show a direct association of a PTP with an ion channel. Receptor PTP-
, a receptor PTP whose mRNA is highly expressed in the brain and
kidney (195), interacts with neuronal Na+
channel
- and
1-subunits through intracellular
domains of the proteins (187). In HEK 293 cells, the
recombinant
-subunit is tyrosine phosphorylated under basal
conditions, and the level of phosphorylation increases after treatment
with the phosphatase inhibitor sodium pervanadate. Coexpression of
-subunits with receptor PTP-
intracellular phosphatase domains
results in an increase in Na+ current due to a rightward
shift in voltage-dependent inactivation. Thus interaction of the
phosphatase and the channel leads to a reversal of the inhibition by
tyrosine phosphorylation (75, 187). The extent to which
the actions of endogenous tyrosine kinases and phosphatases
differentially modulate VGNa under basal conditions, or in response to
hormonal modulation, is not yet known.
Epithelial Na+ Channels
ENaC are important in fluid transport and osmoregulation in epithelia of the airway, colon, kidney, and exocrine glands. ENaCs are composed of three subunits:
,
, and
, with uncertain
stoichiometry; all three are necessary, however, for maximal channel
activity. The putative topology of each subunit is a protein containing two transmembrane domains with intracellular NH2- and
COOH-terminal regions (218). ENaCs are not voltage gated
in their unphosphorylated state, but gating becomes voltage dependent
after phosphorylation by PKA (95). Epithelial
Na+ channel activity is also regulated by PKC, arachidonic
acid metabolites, and possibly by the cytoskeleton, because the
-subunit can bind to spectrin and F-actin (282) and
various SH3 domain proteins (139).
Many studies have documented the effects of growth factors on enhancing expression of ion channels, including ENaC, in transporting epithelia. A few of these studies have also noted that PTK inhibitors have apparently acute effects on channels involved in osmoregulation (234). For example, in renal A6 cells, genistein and tyrphostin A23 abolish macroscopic ENaC currents that are elicited by hyposmotic swelling (159). However, this effect is mimicked by an inhibitor of protein translocation, brefeldin A, suggesting that a PTK might not be regulating the channel directly but regulating its insertion into the plasma membrane. It should be noted that interpretation of some of these studies is complicated by the fact that several types of channels interact to determine epithelial water and solute transport, and, in many cases, direct measurements from specific channels have not been made. For example, the RVD of epithelial cells in response to osmotic swelling is sensitive to PTK inhibition (234), but RVD depends on the summed interaction of multiple channels. In addition, these channels functionally interact with transporters, several of which are also known to be sensitive to PTK inhibitors (134, 158).
| |
REGULATION OF RACC AND CATION CHANNELS BY PTKS |
|---|
CHANNELS...
|
|---|
In many types of cells, Ca2+-permeable channels can be activated by agonist-receptor interaction, where the receptor protein is distinct from the channel protein. This broad group of channels varies widely in conductance, voltage sensitivity, ion selectivity (e.g., Ca2+ vs. monovalent cation permeability), mechanism of activation, and Ca2+-induced inactivation. Most of these channels have not yet been cloned, so it is difficult to classify them and to define the precise mechanisms by which they are regulated. Barritt (15) has proposed that the commonly used term "receptor-activated Ca2+ channel" (RACC) be used to include non-voltage-gated, Ca2+-permeable channels that are activated by Ca2+ store depletion or second messengers, including Ca2+, Ins(1,4,5)P3, cyclic nucleotides, and G proteins. We will adhere to this convention.
A complete description of the evidence for regulation of RACCs by
tyrosine phosphorylation is difficult to compile and categorize, and
the reader is referred to recent reviews for more information (15, 53, 167, 240). Table 5
summarizes much of the available data, although it should be noted
that, in many cases, electrophysiological measurements were not made
and the identity of the specific Ca2+ or cation channel is
uncertain.
|
Store-Operated Channels
A dominant Ca2+ entry pathway in nonexcitable cells is thought to be a plasma membrane Ca2+ channel whose opening is linked to the state of filling of Ca2+ stores. This mechanism has most commonly been termed "store-operated" or "capacitative" Ca2+ influx (182) and is thought to be responsible for refilling endoplasmic reticulum stores and/or the plateau phase of receptor-coupled Ca2+ influx. The characteristics of the channel mediating this influx appear to vary with cell type and with the stimulus that initiates Ca2+ store depletion.Stimulation of receptor or nonreceptor PTKs is a well-known stimulator of Ca2+ influx in nonexcitable cells (19, 202), and there are numerous reports that PTK inhibitors interfere with capacitative Ca2+ influx (152). The majority of these studies are documented in Table 5.
The first electrophysiological description of a store-operated Ca2+ current was of a small inward current in mast cells, termed Icrac (82). Icrac is activated after store depletion by Ins(1,4,5)P3, EGTA, or SERCA inhibitors, is highly Ca2+ selective, voltage independent, and has an extremely low single channel conductance that can only be estimated from noise analysis (83, 283). Icrac is distinct from other cation-permeable channels, and no specific pharmacological antagonist has been identified (121, 167). Some investigators have distinguished at least two different non-voltage-gated Ca2+ currents in the same cell type (52, 55), including Icrac. In some nonexcitable cells, store-operated Ca2+ currents appear to be less selective for divalent over monovalent cations than Icrac (54, 205, 242) and occasionally display measurable single channel currents (242). Some investigators maintain that these differences represent two distinct types of currents rather than a single family of store-operated currents (167).
At least one report suggests that Icrac may be regulated, perhaps weakly, by PTKs (168). Resolution of this issue is limited by the fact that the molecular nature of the native store-operated channel has not been definitively resolved. The best candidates for a store-operated channel are the Trp family of proteins isolated from Drosophila photoreceptors (150) and from their human homologs (259, 281). Recombinant Trp channels share many, but not all, characteristics of Icrac (149, 167). However, heterologous combinations of Trp isoforms in native cells may account for the unique characteristics of endogenous store-operated currents (93, 176). The mechanism of activation of store-operated channels is highly controversial, but recent evidence links their activation with possible conformational coupling of the Ins(1,4,5)P3 receptor to Trp channels (130, 169). This process requires the cytoskeleton because it is disrupted by cytochalasin or by cortical condensation of actin (169, 190). One Trp isoform has even been shown to contain intrinsic kinase activity (193).
Soluble PTK inhibitors such as genistein, lavendustin A, tyrphostin 47, and MDHC impair capacitative Ca2+ entry (8, 99, 163, 168, 175, 196, 197, 206, 280), whereas vanadate enhances capacitative Ca2+ entry (280). On the basis of these effects, it is proposed that the levels of cytosolic and stored Ca2+ antagonistically control tyrosine phosphorylation of a store-operated channel and/or protein involved in regulation of that channel (246). Indeed, in platelets and fibroblasts, store-operated Ca2+ influx is associated with tyrosine phosphorylation of a 130-kDa protein (116, 196, 246). Unfortunately, few of these studies have used electrophysiological methods to measure store-operated current (except Refs. 168, 175, and 206) and instead infer properties of the underlying channel(s) from measurements of cytosolic [Ca2+]. Thus a common concern with these studies is that Ca2+ influx may have changed with changes in membrane potential due to effects of the inhibitors on other channels. In fact, it is likely that these inhibitors have effects of K+ channels because of the rigorous evidence supporting regulation of K+ channels by tyrosine phosphorylation (Table 2). The observation that in several of these studies some, but not most, soluble PTK inhibitors inhibit capacitative Ca2+ influx (8, 167, 175) raises concern about inhibitor specificity. Alternatively, inhibitors that do not affect store-operated Ca2+ influx or current may simply be acting on PTKs that are not involved the regulation of store-operated channels. Thus a definitive role for tyrosine phosphorylation in the regulation of store-operated Ca2+ channels, including Icrac, remains to be proven.
However, there is substantial evidence that a nonselective cation current in vascular smooth muscle is regulated by tyrosine phosphorylation. In cells isolated from the rabbit portal vein, dialysis with a Src-activating peptide or bath application of insulin activates a 20-pS inward cation current (4). This current has the same characteristics as the current activated by noradrenaline, and the noradrenaline current is inhibited by soluble tyrosine kinase inhibitors. Inhibition of PTPs by sodium orthovanadate also activates the cation current (4). Thus receptor and nonreceptor tyrosine kinases appear to regulate a cation current in this tissue. A recent study provides evidence that this channel may represent a combination of one or more Trp isoforms (93).
CNG Cation Channels
CNG channels play a critical role in vertebrate phototransduction and other cellular processes. For example, light triggers an increase in cytosolic cGMP, which alters channel gating, and this process is regulated by multiple factors, including intracellular Ca2+, CaM, and serine-threonine phosphorylation. The CNG channel protein is heteromeric, consisting of
- and
-subunits
(277). Functional channels can be formed by expression of
the
-subunit alone (147), but the complete role of the
-subunit remains to be defined.
One type of CNG channel is a voltage-gated cation channel found in bag cell neurons of Aplysia. In this cell, elevations in cAMP trigger a depolarization that leads to repetitive action potential firing. The cation channel is regulated by an endogenous PTP (267), and there is an interesting interaction between serine phosphorylation and tyrosine phosphorylation. The tyrosine phosphorylation state of the channel determines the response of the channel to PKA phosphorylation, i.e., whether PKA will produce an increase or decrease in Po (267).
In expressed CNG channels, PTK inhibitors, but not serine-threonine
inhibitors, enhance channel sensitivity to cGMP (148). The
-subunit of bRET contains a critical phosphorylation site, Tyr498, on the COOH-terminus that is required for altering
cGMP sensitivity (147). Dephosphorylation of this tyrosine
residue enhances channel Po. Mutation of this
site, Tyr498 to Phe498, but neither of two
other COOH-terminal tyrosine residues nor any of several
NH2-terminal residues required for CaM regulation, abolishes ~75% of the regulation by cGMP. Moreover,
introduction of a tyrosine residue at a comparable site,
Phe477 to Tyr477, on the rOLF channel confers
partial cGMP sensitivity to the otherwise insensitive native rOLF
channel (147). It is interesting that the predicted
position of this tyrosine residue is between the ligand-binding site
and the rest of the channel protein, i.e., in a strategic position to
modulate allosteric gating transitions (147). These
results firmly support the idea that the CNG channel is regulated by
tyrosine phosphorylation, probably at multiple sites, because mutation
of this COOH-terminal tyrosine determines most, but not all, of the
cGMP sensitivity. The role of other possible tyrosine phosphorylation
sites on this channel and the importance of this mechanism in vivo
remain to be determined.
| |
REGULATION OF CL CHANNELS BY PTK |
|---|
CHANNELS...
|
|---|
Non-ligand-gated Cl
channels have been grouped into
four families: 1) Ca2+-activated
Cl
channels, 2) voltage-dependent
Cl
channels, 3) ClC voltage-gated
Cl
channels, and 4) the CFTR channel
(58, 244). Many of the first two classes of
Cl
channels have not yet been purified and cloned, so
identification is based completely on their ion selectivity,
pharmacology, current-voltage relationship, and Ca2+
sensitivity. In contrast, much is known about the structure and function of ClC and CFTR channels (100, 110).
ClC channels have membrane topography quite different from
voltage-gated cation channels in that they contain 11 transmembrane domains. Yet, like cation channels, both NH2- and
COOH-termini are intracellular. ClC-0 channels have two identical, yet
independent, conductance levels, leading to the conclusion that there
are two pores in each channel (244). ClC-2 and ClC-3 are
thought to conduct the swelling-activated Cl
current
observed in many cell types. A serine residue (S51) in the
ClC-3 NH2-terminus has recently been shown to be a
consensus PKC phosphorylation site that determines volume sensitivity
(46).
CFTR is a cAMP-regulated Cl
channel that controls salt
and water transport across epithelia. It is composed of five
membrane-spanning domains and two nucleotide-binding domains linked to
a unique, regulatory (R) domain (211). The cytosolic R
domain of CFTR contains multiple serine phosphorylation sites, at least
five of which are phosphorylated by PKA to stimulate channel activity.
PKC phosphorylation may play a facilatory role in PKA phosphorylation
of CFTR (211). The NH2-terminus of CFTR binds
to the scaffolding protein syntaxin 1A, which appears to exert a tonic
inhibitory role on the channel. The COOH-terminus of CFTR binds to
several PDZ domain proteins that could potentially link to PTKs and
cytoskeletal proteins. It has been proposed that this region of the
channel may be involved in formation of a multiprotein signaling
complex (110).
At least one study has suggested that CFTR gating is regulated by
tyrosine phosphorylation independent of PKA (56).
pp60Src was implicated in channel regulation, but a
putative tyrosine phosphorylation site was not identified. Furthermore,
it is not known if the CFTR NH2- or COOH-termini contain a
Src recognition site. It is possible that a PTK only indirectly
regulates CFTR function, e.g., by phosphorylating PKC, in a similar
manner to the mechanism by which tyrosine phosphorylation of PLC-
modulates Cl
current in mesangial cells
(132). This would be consistent with the inability of some
investigators to detect phosphotyrosines in biochemical assays of CFTR
(177).
Specific mechanisms by which other Cl
channels may be
regulated by tyrosine phosphorylation are largely unknown (58,
108). As with other channels, a number of studies have shown
that Cl
currents are modulated by soluble PTK and PTP
inhibitors. This literature is summarized in Table
6.
|
One series of studies stands out. Lepple-Wienhues et al.
(118, 119) showed that a native swelling-activated
Cl
channel in lymphocytes (presumably a ClC family
member) is regulated by p56Lck tyrosine kinase
(118). This channel is activated by osmotic swelling and by cAMP, and the process is blocked by genistein or
lavendustin A. Furthermore, osmotic swelling produces an increase in
p56Lck activity (118). Addition of purified
p56Lck activates a Cl
conductance in the
absence of swelling. Osmotic activation of the channel is defective in
lymphocytes from p56Lck knockout animals but rescued after
transfection with cDNA for p56Lck. Although it is not known
if the channel is tyrosine phosphorylated by p56Lck or in
response to swelling, the collective evidence strongly suggests that
Lck regulates this Cl
channel. In a subsequent study, it
was shown that osmotic swelling or purified p56Lck can
activate the same channel in lymphocytes from patients with cystic
fibrosis, suggesting that the channel may partially compensate for
defective CFTR (119). Regulation of other ClC channels by PTKs, or even whether other ClC channels contain potential tyrosine phosphorylation sites on their NH2- or COOH-termini, are
issues that remain to be resolved.
| |
THE CHANNEL-PROTEIN KINASE REGULATORY COMPLEX |
|---|
CHANNELS...
|
|---|
It is becoming clear that regulation of an ion channel by a
protein kinase requires the formation of a multiprotein complex. While
pore-forming
-subunits of many channels bind to auxiliary channel
subunits, they also associate with scaffolding proteins that play
essential roles in channel localization and activity (124). Scaffolding proteins link signaling enzymes,
substrates, and potential effectors (such as channels) into a
multiprotein signaling complex that may be anchored to the
cytoskeleton. Besides an obvious role in targeting the channel to a
particular location on the cell membrane, there are at least three
advantages to having an ion channel in a multiprotein complex. First,
there is a large increase in the efficiency of the kinetic reaction
when an enzyme is localized with its substrate and effector in a
microenvironment with restricted diffusion (188). Second,
the anchoring of enzyme complexes to some channels may be necessary for
the extremely rapid transmission of signals required to regulate some
channels (273). Third, compartmentalization may be
essential to determining specificity in signal transduction pathways
(37).
There appear to be many families of scaffolding and adaptor proteins that could potentially be involved in organizing ion channels into signaling complexes and regulating function by coupling the channels to protein kinases. For serine-threonine kinases, the prominent families are the MAGUK protein, AKAP, and GKAP families (73). Another family of proteins that specifically associates with Kv4.x channels has also recently been described (73). Many scaffolding protein-channel interactions have been identified using yeast two-hybrid screens followed by subsequent immunoprecipitation and GST-fusion protein strategies. In most cases, however, the evidence for an anatomic relationship between the channel and other proteins is stronger than the evidence for a functional relationship. It is beyond the scope of this review to exhaustively discuss the evidence for channel-associated proteins in ion channel regulation (207), but examples from several classes of scaffolding proteins are worth mentioning because PTKs are also associated with some of the same proteins.
MAGUK proteins contain three types of domains that function as sites for specific protein-protein interactions: PDZ, SH3, and GK-like domains. Adjacent GK and SH3 domains, in which the GK domains appear to lack enzymatic activity (180), are defining features of MAGUKs. SH3 domains are proline-rich amino acid sequences found in many signaling and cytoskeleton-associated molecules (170). PDZ domains contain 80-100 amino acids and have been found in many proteins, including 30% of G protein-coupled receptors (186). Although MAGUK proteins are involved in directing protein associations apart from ion channels, there is evidence to support their role in the intracellular localization of several types of channels. Members of this family appear to be essential for proper organization of ion channels at neuronal synapses. For example, colocalization of Shaker family K+ channels with NMDA receptors in neuronal synapses requires PSD-95, SAP97, Chapsyn-110, SAP102, and Dlg, among other scaffolding proteins (208). There are many other examples encompassing both voltage-gated and ligand-gated families of channels (180, 207).
Importantly, the available evidence suggests that the association of scaffolding proteins with channels is part of a general mechanism that not only directs channel localization within a cell but is also essential for regulation of channel function. For example, localization of Shaker Kv1.4c is mediated by the binding of two PDZ domains of PSD-95 to the COOH-terminal cytoplasmic tail of the channel (109). Coexpression of PSD-95 with Kir2.3 in HEK 293 cells suppresses the activity of that channel by >50% (156). SAP97 is required for normal G protein sensitivity of Kir3.2c, an effect mediated through the GK domain of SAP97 (73). Syntaxin, which is abundant in nerve terminals, interacts with voltage-gated Ca2+ channels (18, 209, 210, 269) to shift their voltage dependence of inactivation in a direction that would inhibit presynaptic Ca2+ entry (18). One example that is not specific to the neuronal synapse is syntaxin 1A. That protein interacts with CFTR to tonically inhibit the channel (155). Future studies will likely reveal roles for these or related scaffolding/adaptor proteins in the normal functioning of other channels.
Some channel-associated proteins containing PDZ domains do not belong to the MAGUK protein family. Examples of these include GRIP (44) and Homer (26), which are important for localization of glutamate-gated channels. Most notably, INAD is a Drosophila protein containing five PDZ domains that link together most of the proteins involved directly in phototransduction. This multiprotein complex includes rhodopsin, CaM, the putative store-operated Ca2+ channels Trp and Trpl, and the protein kinases PLC and PKC (88, 273). INAD may serve as a template for understanding how other channels are regulated in a multiprotein complex.
Although the association of other ion channels with PDZ domain proteins
and protein kinases is not as firmly established as for INAD, several
ion channel-associated PDZ domain proteins do contain catalytic domains
(180). Additionally, some of these same proteins contain
other signaling domains, e.g., SH3, PH, PTB, PX, and DEP
(180), implying that they also associate with other
regulatory proteins. As mentioned above, SH3 domains are found in many
cytoskeletal and focal adhesion proteins and in most PTKs
(247). The
1-subunit of L- and N-type
Ca2+ channels has a conserved sequence of proline-rich
residues (Prp2039-Pro2194) containing a
number of potential SH3-binding motifs (PxxP). This region encompasses
part of the channel known to be involved in G protein regulation by

-subunits (183) and has been shown to bind Src, Lyn,
and Hck tyrosine kinases, although the functional significance of these
interactions (except for Src, see Ref. 16) is not yet
known (63). However, mutant
1C lacking the
proline-rich domain exhibits enhanced cation current conduction,
consistent with an autoinhibitory role for the COOH-terminus
(258). Another sequence at the COOH-terminus of
1B contains a conserved DxxC-COOH motif that allows
interaction with PDZ domain proteins such as the scaffolding protein
Mint1 through a class III PDZ domain of the latter (137).
Furthermore, a proline-rich domain elsewhere in Mint1 interacts with
the SH3 domain of CASK, an adaptor protein that contains a calmodulin
kinase domain (137). These observations point to the
likely possibility that combinations of PDZ, SH3, and other signaling
domain sequences may direct protein-protein interactions between ion
channels and the kinases that regulate them.
Evidence that scaffolding proteins can mediate kinase-channel
interactions is more firmly established for the AKAP family of proteins
(66). AKAPs serve to localize both kinases and
phosphatases to multiprotein effector complexes that include
K+ and Ca2+ channels (41).
Evidence for AKAP participation in ion channel regulation has been
obtained using both molecular biology and electrophysiology approaches.
A general scheme is that a conserved AKAP-anchoring motif directs
dimerized PKA subunits to a particular subcellular target
(102). For example, forskolin and cAMP potentiate ROMK1
(Kir1.x) current in native renal secretory cells (251). Activity is preserved after patch excision, in which the excised membrane is known to retain channel-associated proteins. However, this
potentiation is lost when ROMK1 is expressed in oocytes but restored if
AKAP79 is coexpressed with the channel (251). AKAP15/18 is
required for PKA potentiation of L-type Ca2+ channels in
cardiac (62), skeletal (103), and vascular
smooth muscle (60). In skeletal muscle, AKAP15 also aids
in localizing L-type Ca2+ channels to transverse tubules
(65). AKAPs have also been implicated in the regulation of
KCa channels (256) and CFTR
(225). AKAP79 associates with both the
2-adrenergic receptor and MAGUK proteins, and the latter
are coupled to glutamate-gated ion channels. Although it has not yet
been proven, AKAP79 has the potential to form part of a scaffold on
which PKA and PP2B may dually regulate the coupling of
2-adrenergic receptors and glutamate channels
(41). Thus AKAPs appear to be capable of assembling
signaling complexes by virtue of their associations with other
scaffolding proteins. It is possible that AKAPs and INAD represent a
general scheme for kinase regulation of channels and that similar
families of adaptor proteins associated with other kinases, perhaps
PTKs, will soon be identified.
| |
CONCLUSIONS AND FUTURE DIRECTIONS |
|---|
CHANNELS...
|
|---|
It should be apparent that there is strong collective evidence to support a role for regulation of ion channels by tyrosine phosphorylation, particularly for ligand-gated channels and voltage-gated cation channels. Our knowledge of the importance of this mechanism for the regulation of other channels will depend largely on the isolation, purification, and cloning of those channels.
On the basis of the evidence described herein, several remaining questions can be identified. What specific PTKs, receptor and nonreceptor, are directly responsible for tyrosine phosphorylation of a particular channel? Can more than one PTK control phosphorylation of a given tyrosine residue on a channel? Are there interactions between tyrosine phosphorylation sites on a channel (5)? Are there interactions between tyrosine phosphorylation sites and serine-threonine phosphorylation sites (267)? What specific endogenous tyrosine phosphatases are involved in ion channel regulation (187)?
Little information is currently available regarding scaffolding and adaptor proteins that might specifically be required for regulation of ion channels by tyrosine phosphorylation. This field lags considerably behind that for serine-threonine phosphorylation systems, but AKAPs, CFTR, and INAD systems may serve as useful models to guide future study.
Finally, a major issue needing to be resolved for virtually every class of ion channel is the physiological role for tyrosine phosphorylation. Many questions remain to be answered. Is there a significant impact of tyrosine phosphorylation on channel function, membrane potential, and/or [Ca2+]i regulation? Does tyrosine phosphorylation produce the same effect on native channels in vivo as it does on recombinant channels in vitro? Is this type of regulation determined by or modified by auxiliary channel subunits (219)? We discussed evidence for physiological relevance, when known, in each of the above sections dealing with specific families of channels. In general, acute regulation of an ion channel by a growth factor (in addition to any effect on channel protein expression) may represent an adaptive mechanism that could be enhanced or unmasked in processes such as tissue repair or remodeling. Moreover, because signaling pathways for nonreceptor tyrosine kinases and growth factors overlap, and in some cases converge on ion channels, it is possible that the adhesion molecules linked to those kinases play a physiological role in the regulation of the channels. This implies that tyrosine phosphorylation may be one mechanism for transduction of mechanical forces through adhesion molecules to ion channels.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Judy Davidson for extensive assistance in preparing and proofreading the manuscript.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-46502 and HL-60180 (to M. J. Davis).
Address for reprint requests and other correspondence: M. J. Davis, Dept. of Medical Physiology, Rm. 346, Reynolds Medical Bldg., Texas A&M Univ., College Station, TX 77843-1114 (E-mail: mjd{at}tamu.edu).
| |
REFERENCES |
|---|
CHANNELS...
|
|---|
1.
Abram, CL,
and
Courtneidge SA.
Src family tyrosine kinases and growth factor signaling.
Exp Cell Res
254:
1-13,
2000[Web of Science][Medline].
2.
Akiyama, T,
Ishida J,
Nakagawa S,
Ogawara H,
Watanabe S,
Itoh N,
Shibuya M,
and
Fukama Y.
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
J Biol Chem
262:
5592-5595,
1987
3.
Akiyama, T,
and
Ogawara H.
Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
Methods Enzymol
201:
362-370,
1991[Web of Science][Medline].
4.
Albert, AP,
Aromolaran AS,
and
Large WA.
Agents that increase tyrosine phosphorylation activate a non-selective cation current in single rabbit portal vein smooth muscle cells.
J Physiol (Lond)
530:
207-217,
2001
5.
Ali, N,
and
Agrawal DK.
Guanine nucleotide binding regulatory proteins: their characteristics and identification.
J Pharmacol Toxicol Methods
32:
187-196,
1994[Web of Science][Medline].
6.
Amico, C,
Cupello A,
Fossati C,
and
Robello M.
Involvement of phosphatase activities in the run-down of GABAA receptor function in rat cerebellar granule cells in culture.
Neuroscience
84:
529-535,
1998[Web of Science][Medline].
7.
Anders, DL,
Blevins T,
Sutton G,
Swope S,
Chandler LJ,
and
Woodward JJ.
Fyn tyrosine kinase reduces the ethanol inhibition of recombinant NR1/NR2A but not NR1/NR2B NMDA receptors expressed in HEK 293 cells.
J Neurochem
72:
1389-1393,
1999[Web of Science][Medline].
8.
Aptel, HB,
Burnay MM,
Rossier MF,
and
Capponi AM.
The role of tyrosine kinases in capacitative calcium influx-mediated aldosterone production in bovine adrenal zona glomerulosa cells.
J Endocrinol
163:
131-138,
1999[Abstract].
9.
Arcangeli, A,
Becchetti A,
Mannini A,
Mugnai G,
De Filippi P,
Tarone G,
Del Bene MR,
Barletta E,
Wanke E,
and
Olivotto M.
Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels.
J Cell Biol
122:
1131-1143,
1993
10.
Archer, SL,
Huang JMC,
Hampl V,
Nelson DP,
Shultz PJ,
and
Weir EK.
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.
Proc Natl Acad Sci USA
91:
7583-7587,
1994
11.
Arnoult, C,
Lemos JR,
and
Florman HM.
Voltage-dependent modulation of T-type calcium channels by protein tryosine phosphorylation.
EMBO J
16:
1593-1599,
1997[Web of Science][Medline].
12.
Avraham, H,
Park SY,
Schinkmann K,
and
Avraham S.
RAFTK/Pyk2-mediated cellular signalling.
Cell Signal
12:
123-133,
2000[Web of Science][Medline].
13.
Babnigg, G,
Bowersox SR,
and
Villereal ML.
The role of pp60c-src in the regulation of calcium entry via store-operated calcium channels.
J Biol Chem
272:
29434-29437,
1997
14.
Baldelli, P,
Magnelli V,
and
Carbone E.
Selective up-regulation of P- and R-type Ca2+ channels in rat embryo motoneurons by BDNF.
Eur J Neurosci
11:
1127-1133,
1999[Web of Science][Medline].
15.
Barritt, GJ.
Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements.
Biochem J
337:
153-169,
1999.
16.
Bence-Hanulec, KK,
Marshall J,
and
Blair LA.
Potentiation of neuronal L calcium channels by IGF-1 requires phosphorylation of the
1 subunit on a specific tyrosine residue.
Neuron
27:
121-131,
2000[Web of Science][Medline].
17.
Berts, A,
and
Minneman KP.
Tyrosine kinase inhibitors and Ca2+ signaling: direct interactions with fura-2.
Eur J Pharmacol
389:
35-40,
2000[Web of Science][Medline].
18.
Bezprozvanny, I,
Scheller RH,
and
Tsien RW.
Functional impact of syntaxin on gating of N-type and Q-type calcium channels.
Nature
378:
623-626,
1995[Medline].
19.
Bhattacharya, S,
Ying X,
Fu C,
Patel R,
Kuebler W,
Greenberg S,
and
Bhattacharya J.
v
3 Integrin induces tyrosine phosphorylation-dependent Ca2+ influx in pulmonary endothelial cells.
Circ Res
86:
456-462,
2000
20.
Bischof, G,
Illek B,
Reenstra WW,
and
Machen TE.
Role for tyrosine kinases in carbachol-regulated Ca entry into colonic epithelial cells.
Am J Physiol Cell Physiol
268:
C154-C161,
1995
21.
Blair, LA,
and
Marshall J.
IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner.
Neuron
19:
421-429,
1997[Web of Science][Medline].
22.
Boixel, C,
Tessier S,
Pansard Y,
Lang-Lazdunski L,
Mercadier JJ,
and
Hatem SN.
Tyrosine kinase and protein kinase C regulate L-type Ca2+ current cooperatively in human atrial myocytes.
Am J Physiol Heart Circ Physiol
278:
H670-H676,
2000
23.
Bolotina, VM,
Najibi S,
Palacino JJ,
Pagano PJ,
and
Cohen RA.
Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.
Nature
368:
850-853,
1994[Medline].
24.
Bowlby, MR,
Fadool DA,
Holmes TC,
and
Levitan IB.
Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases.
J Gen Physiol
110:
601-610,
1997
25.
Boxall, AR,
and
Lancaster B.
Tyrosine kinases and synaptic transmission.
Eur J Neurosci
10:
2-7,
1998[Web of Science][Medline].
26.
Brakeman, PR,
Lanahan AA,
O'brien R,
Roche K,
Barnes CA,
Huganir RL,
and
Worley PF.
Homer: a protein that selectively binds metabotropic glutamate receptors.
Nature
386:
284-288,
1997[Medline].
27.
Bryan-Sisneros, A,
Sabanov V,
Thoroed SM,
and
Doroshenko P.
Dual role of ATP in supporting volume-regulated chloride channels in mouse fibroblasts.
Biochim Biophys Acta
1468:
63-72,
2000[Medline].
28.
Cantrell, AR,
Smith RD,
Goldin AL,
Scheuer T,
and
Catterall WA.
Dopaminergic modulation of sodium current in hippocampal neurons via cAMP-dependent phosphorylation of specific sites in the sodium channel alpha subunit.
J Neurosci
17:
7330-7338,
1997
29.
Castel, H,
Louiset E,
Anouar Y,
Le Foll F,
Cazin L,
and
Vaudry H.
Regulation of GABAA receptor by protein tyrosine kinases in frog pituitary melanotrophs.
J Neuroendocrinol
12:
41-52,
2000[Web of Science][Medline].
30.
Cataldi, M,
Taglialatela M,
Guerriero S,
Amoroso S,
Lombardi G,
Di Renzo G,
and
Annunziato L.
Protein-tyrosine kinases activate while protein-tyrosine phosophatases inhibit L-type calcium channel activity in pituitary GH3 cells.
J Biol Chem
271:
9441-9446,
1996
31.
Chapron, Y,
Cochet C,
Crouzy S,
Jullien T,
Keramidas M,
and
Verdetti J.
Tyrosine protein kinase activity of the EGF receptor is required to induce activation of receptor-operated calcium channels.
Biochem Biophys Res Commun
158:
527-533,
1989[Web of Science][Medline].
32.
Chauhan-Patel, R,
and
Spruce AE.
Differential regulation of potassium currents by FGF-1 and FGF-2 in embryonic Xenopus laevis myocytes.
J Physiol (Lond)
512:
109-118,
1998
33.
Chiang, CE,
Chen SA,
Chang MS,
Lin CI,
and
Luk HN.
Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes.
Biochem Biophys Res Commun
223:
598-603,
1996[Web of Science][Medline].
34.
Chik, CL,
Li B,
Karpinski E,
and
Ho AK.
Insulin and insulin-like growth factor-I inhibit the L-type calcium channel current in rat pinealocytes.
Endocrinology
138:
2033-2042,
1997
35.
Colledge, M,
and
Froehner SC.
Tyrosine phosphorylation of nicotinic acetylcholine receptor mediates Grb2 binding.
J Neurosci
17:
5038-5045,
1997
36.
Colledge, M,
and
Froehner SC.
Signals mediating ion channel clustering at the neuromuscular junction.
Curr Opin Neurobiol
8:
357-363,
1998[Web of Science][Medline].
37.
Colledge, M,
and
Scott JD.
AKAPs: from structure to function.
Trends Cell Biol
9:
216-221,
1999[Web of Science][Medline].
38.
De Jongh, KS,
Murphy BJ,
Colvin AA,
Hell JW,
Takahashi M,
and
Catterall WA.
Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3',5'-cyclic monophosphate-dependent protein kinase.
Biochemistry
35:
10392-10402,
1996[Medline].
39.
Delbono, O,
Renganathan M,
and
Messi ML.
Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor.
J Neurosci
17:
6918-6928,
1997
40.
Disalvo, J,
Pfitzer G,
and
Semenchuck LA.
Protein tyrosine phosphorylation, cellular Ca2+, and Ca2+ sensitivity for contraction of smooth muscle.
Can J Physiol Pharmacol
72:
1434-1439,
1994[Web of Science][Medline].
41.
Dodge, K,
and
Scott JD.
AKAP79 and the evolution of the AKAP model.
FEBS Lett
476:
58-61,
2000[Web of Science][Medline].
42.
Dolly, JO,
and
Parcej DN.
Molecular properties of voltage-gated K+ channels.
J Bioenerg Biomembr
28:
231-253,
1996[Web of Science][Medline].
43.
Dolly, JO,
Rettig J,
Scott VE,
Parcej DN,
Wittkat R,
Sewing S,
and
Pongs O.
Oligomeric and subunit structures of neuronal voltage-sensitive K+ channels.
Biochem Soc Trans
22:
473-478,
1994[Web of Science][Medline].
44.
Dong, H,
O'Brien RJ,
Fung ET,
Lanahan AA,
Worley PF,
and
Huganir RL.
GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors.
Nature
386:
279-284,
1997[Medline].
45.
Doroshenko, P.
Pervanadate inhibits volume-sensitive chloride current in bovine chromaffin cells.
Pflügers Arch
435:
303-309,
1998[Web of Science][Medline].
46.
Duan, D,
Cowley S,
Horowitz B,
and
Hume JR.
A serine residue in ClC-3 links phosphorylation-dephosphorylation to chloride channel regulation by cell volume.
J Gen Physiol
113:
57-70,
1999
47.
Ertel, EA,
Campbell KP,
Harpold MM,
Hofmann F,
Mori Y,
Perez-Reyes E,
Schwartz A,
Snutch TP,
Tanabe T,
Birnbaumer L,
Tsien RW,
and
Catterall WA.
Nomenclature of voltage-gated calcium channels.
Neuron
25:
533-535,
2000[Web of Science][Medline].
48.
Evans, GJO,
and
Pocock JM.
Modulation of neurotransmitter release by dihydropyridine-sensitive calcium channels involves tyrosine phosphorylation.
Eur J Neurosci
11:
279-292,
1999[Web of Science][Medline].
49.
Fadool, DA,
Holmes TC,
Berman K,
Dagan D,
and
Levitan IB.
Tyrosine phosphorylation modulates current amplitude and kinetics of a neuronal voltage-gated potassium channel.
J Neurophysiol
78:
1563-1573,
1997
50.
Fadool, DA,
and
Levitan IB.
Modulation of olfactory bulb neuron potassium current by tyrosine phosphorylation.
J Neurosci
18:
6126-6137,
1998
51.
Fantl, WJ,
Johnson DE,
and
Williams LT.
Signalling by receptor tyrosine kinases.
Annu Rev Biochem
62:
453-481,
1993[Web of Science][Medline].
52.
Fasolato, C,
Hoth M,
Matthews G,
and
Penner R.
Ca2+ and Mn2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells.
Proc Natl Acad Sci USA
90:
3068-3072,
1993
53.
Fasolato, C,
Innocenti B,
and
Pozzan T.
Receptor-activated Ca2+ influx: how many mechanisms for how many channels?
Trends Pharmacol Sci
15:
77-83,
1994[Medline].
54.
Fasolato, C,
and
Nilius B.
Store depletion triggers the calcium release-activated calcium current (ICRAC) in macrovascular endothelial cells: a comparison with Jurkat and embryonic kidney cell lines.
Pflügers Arch
436:
69-74,
1998[Web of Science][Medline].
55.
Fernando, KC,
and
Barritt GJ.
Characterisation of the divalent cation channels of the hepatocyte plasma membrane receptor-activated Ca2+ inflow system using lanthanide ions.
Biochim Biophys Acta
1268:
97-106,
1995[Medline].
56.
Fischer, H,
and
Machen TE.
The tyrosine kinase p60c-src regulates the fast gate of the cystic fibrosis transmembrane conductance regulator chloride channel.
Biophys J
71:
3073-3082,
1996[Web of Science][Medline].
57.
Fitzgerald, EM,
and
Dolphin AC.
Regulation of rat neuronal voltage-dependent calcium channels by endogenous p21-ras.
Eur J Neurosci
9:
1252-1261,
1997[Web of Science][Medline].
58.
Frings, S,
Reuter D,
and
Kleene SJ.
Neuronal Ca2+-activated Cl
channels-homing in on an elusive channel species.
Prog Neurobiol
60:
247-289,
2000[Web of Science][Medline].
59.
Fuhrer, C,
and
Hall ZW.
Functional interaction of Src family kinases with the acetylcholine receptor in C2 myotubes.
J Biol Chem
271:
32474-32481,
1996
60.
Fukao, M,
Mason HS,
Britton FC,
Kenyon JL,
Horowitz B,
and
Keef KD.
Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072.
J Biol Chem
274:
10927-10935,
1999
61.
Furukawa, K,
Onodera H,
Kogure K,
and
Akaike N.
Alterations of Ca2+ currents and their sensitivities to Ca2+ antagonists during application and after deprivation of nerve growth factor.
Neurosci Lett
161:
13-16,
1993[Web of Science][Medline].
62.
Gao, T,
Yatani A,
Dell'acqua ML,
Sako H,
Green SA,
Dascal N,
Scott JD,
and
Hosey MM.
cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits.
Neuron
19:
185-196,
1997[Web of Science][Medline].
63.
Gerhardstein, BL,
Gao T,
Bunemann M,
Puri TS,
Adair A,
Ma H,
and
Hosey MM.
Proteolytic processing of the C terminus of the
(1C) subunit of L-type calcium channels and the role of a proline-rich domain in membrane tethering of proteolytic fragments.
J Biol Chem
275:
8556-8563,
2000
64.
Gould, EM,
Rembold CM,
and
Murphy RA.
Genistein, a tyrosine kinase inhibitor, reduces Ca2+ mobilization in swine carotid media.
Am J Physiol Cell Physiol
268:
C1425-C1429,
1995
65.
Gray, PC,
Johnson BD,
Westenbroek RE,
Hays LG,
Yates JR, III,
Scheuer T,
Catterall WA,
and
Murphy BJ.
Primary structure and function of an A kinase anchoring protein associated with calcium channels.
Neuron
20:
1017-1026,
1998[Web of Science][Medline].
66.
Gray, PC,
Scott JD,
and
Catterall WA.
Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins.
Curr Opin Neurobiol
8:
330-334,
1998[Web of Science][Medline].
67.
Gronroos, E,
Schippert A,
Engstrom M,
and
Sjolander A.
The regulation of leukotriene D4-induced calcium influx in human epithelial cells involves protein tyrosine phosphorylation.
Cell Calcium
17:
177-186,
1995[Web of Science][Medline].
68.
Gulbins, E,
Szabo I,
Baltzer K,
and
Lang F.
Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases.
Proc Natl Acad Sci USA
94:
7661-7666,
1997
69.
Harder, KW,
Moller NP,
Peacock JW,
and
Jirik FR.
Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion.
J Biol Chem
273:
31890-31900,
1998
70.
Hatakeyama, N,
Mukhopadhyay D,
Goyal RK,
and
Akbarali HI.
Tryosine kinase-dependent modulation of calcium entry in rabbit colonic muscularis mucosae.
Am J Physiol Cell Physiol
270:
C1780-C1789,
1996
71.
Hayashi, T,
Umemori H,
Mishina M,
and
Yamamoto T.
The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn.
Nature
397:
72-76,
1999[Medline].
72.
Herzig, S,
and
Neumann J.
Effects of serine/threonine protein phosphatases on ion channels in excitable membranes.
Physiol Rev
80:
173-210,
2000
73.
Hibino, H,
Inanobe A,
Tanemoto M,
Fujita A,
Doi K,
Kubo T,
Hata Y,
Takai Y,
and
Kurachi Y.
Anchoring proteins confer G protein sensitivity to an inward-rectifier K+ channel through the GK domain.
EMBO J
19:
78-83,
2000[Web of Science][Medline].
74.
Hida, H,
Takeda M,
and
Soliven B.
Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes.
J Neurosci
18:
8712-8719,
1998
75.
Hilborn, MD,
Vaillancourt RR,
and
Rane SG.
Growth factor receptor tyrosine kinases acutely regulate neuronal sodium channels through the src signaling pathway.
J Neurosci
18:
590-600,
1998
76.
Holm, NR,
Christophersen P,
Olesen SP,
and
Gammeltoft S.
Activation of calcium-dependent potassium channels in mouse brain neurons by neurotrophin-3 and nerve growth factor.
Proc Natl Acad Sci USA
94:
1002-1006,
1997
77.
Holmes, TC,
Berman K,
Swartz JE,
Dagan D,
and
Levitan IB.
Expression of voltage-gated potassium channels decreases cellular protein tyrosine phosphorylation.
J Neurosci
17:
8964-8974,
1997
78.
Holmes, TC,
Fadool DA,
and
Levitan IB.
Tyrosine phosphorylation of the Kv1.3 potassium channel.
J Neurosci
16:
1581-1590,
1996
79.
Holmes, TC,
Fadool DA,
Ren RB,
and
Levitan IB.
Association of Src tyrosine kinase with a human potassium channel mediated by SH3 domain.
Science
274:
2089-2091,
1996
80.
Hool, LC,
Middleton LM,
and
Harvey RD.
Genistein increases the sensitivity of cardiac ion channels to
-adrenergic receptor stimulation.
Circ Res
83:
33-42,
1998
81.
Hopfield, JF,
Tank DW,
Greengard P,
and
Huganir RL.
Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation.
Nature
336:
677-680,
1988[Medline].
82.
Hoth, M,
and
Penner R.
Depletion of intracellular calcium stores activates a calcium current in mast cells.
Nature
355:
353-356,
1992[Medline].
83.
Hoth, M,
and
Penner R.
Calcium release-activated calcium current in rat mast cells.
J Physiol (Lond)
465:
359-386,
1993
84.
Hu, XQ,
Singh N,
Mukhopadhyay D,
and
Akbarali HI.
Modulation of voltage-dependent Ca2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase.
J Biol Chem
273:
5337-5342,
1998
85.
Huang, R,
and
Dillon GH.
Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor.
Neuropharmacology
39:
2195-2204,
2000[Web of Science][Medline].
86.
Huang, RQ,
Fang MJ,
and
Dillon GH.
The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors.
Brain Res Mol Brain Res
67:
177-183,
1999[Medline].
87.
Huang, XY,
Morielli AD,
and
Peralta EG.
Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor.
Cell
75:
1145-1156,
1993[Web of Science][Medline].
88.
Huber, A,
Sander P,
Bahner M,
and
Paulsen R.
The TRP Ca2+ channel assembled in a signaling complex by the PDZ domain protein INAD is phosphorylated through the interaction with protein kinase C (ePKC).
FEBS Lett
425:
317-322,
1998[Web of Science][Medline].
89.
Huganir, RL.
Regulation of the nicotinic acetylcholine receptor by serine and tyrosine protein kinases.
Adv Exp Med Biol
287:
279-294,
1991[Medline].
90.
Huganir, RL,
Miles K,
and
Greengard P.
Phosphorylation of the nicotinic acetylcholine receptor by an endogenous tyrosine-specific protein kinase.
Proc Natl Acad Sci USA
81:
6968-6972,
1984
91.
Hunter, T,
and
Cooper JA.
Protein-tyrosine kinases.
Annu Rev Biochem
54:
897-930,
1985[Web of Science][Medline].
92.
Illek, B,
Fischer H,
and
Machen TE.
Alternate stimulation of apical CFTR by genistein in epithelia.
Am J Physiol Cell Physiol
270:
C265-C275,
1996
93.
Inoue, R,
Okada T,
Onoue H,
Hara Y,
Shimizu S,
Naitoh S,
Ito Y,
and
Mori Y.
The transient receptor potential protein homologue TRP6 is the essential component of vascular
1-adrenoceptor-activated Ca2+-permeable cation channel.
Circ Res
88:
325-332,
2001
94.
Inoue, R,
Waniishi Y,
Yamada K,
and
Ito Y.
A possible role of tyrosine kinases in the regulation of muscarinic receptor-activated cation channels in guinea pig ileum.
Biochem Biophys Res Commun
203:
1392-1397,
1994[Web of Science][Medline].
95.
Ismailov, II,
and
Benos DJ.
Effects of phosphorylation on ion channel function.
Kidney Int
48:
1167-1179,
1995[Web of Science][Medline].
96.
Isom, LL,
Ragsdale DS,
De Jongh KS,
Westenbroek RE,
Reber BF,
Scheuer T,
and
Catterall WA.
Structure and function of the
2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif.
Cell
83:
433-442,
1995[Web of Science][Medline].
97.
Jan, LY,
and
Jan YN.
Cloned potassium channels from eukaryotes and prokaryotes.
Annu Rev Neurosci
20:
91-123,
1997[Web of Science][Medline].
98.
Jassar, BS,
Ostashewski PM,
and
Jhamandas JH.
GABAA receptor modulation by protein tyrosine kinase in the rat diagonal band of Broca.
Brain Res
775:
127-133,
1997[Web of Science][Medline].
99.
Jenner, S,
Farndale RW,
and
Sage SO.
The effect of calcium-store depletion and refilling with various bivalent cations on tyrosine phosphorylation and Mn2+ entry in fura-2-loaded human platelets.
Biochem J
303:
337-339,
1994.
100.
Jentsch, TJ,
Friedrich T,
Schriever A,
and
Yamada H.
The CLC chloride channel family.
Pflügers Arch
437:
783-795,
1999[Web of Science][Medline].
101.
Jing, J,
Peretz T,
Singer-Lahat D,
Chikvashvili D,
Thornhill WB,
and
Lotan I.
Inactivation of a voltage-dependent K+ channel by
subunit. Modulation by a phosphorylation-dependent interaction between the distal C terminus of
subunit and cytoskeleton.
J Biol Chem
272:
14021-14024,
1997
102.
Johnson, BD.
The company they keep: ion channels and their intracellular regulatory partners.
Adv Second Messenger Phosphoprotein Res
33:
203-228,
1999[Web of Science][Medline].
103.
Johnson, BD,
Scheuer T,
and
Catterall WA.
Voltage-dependent potentiation of L-type Ca2+ channels in skeletal muscle cells requires anchored cAMP-dependent protein kinase.
Proc Natl Acad Sci USA
91:
11492-11496,
1994
104.
Jonas, EA,
and
Kaczmarek LK.
Regulation of potassium channels by protein kinases.
Curr Opin Neurobiol
6:
318-323,
1996[Web of Science][Medline].
105.
Jonas, EA,
Knox RJ,
Kaczmarek LK,
Schwartz JH,
and
Solomon DH.
Insulin receptor in Aplysia neurons: characterization, molecular cloning, and modulation of ion currents.
J Neurosci
16:
1645-1658,
1996
106.
Kamp, TJ,
and
Hell JW.
Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.
Circ Res
87:
1095-1102,
2000
107.
Katsube, Y,
Yokoshiki H,
Nguyen L,
Yamamoto M,
and
Sperelakis N.
Inhibition of Ca2+ current in neonatal and adult rat ventricular myocytes by the tyrosine kinase inhibitor, genistein.
Eur J Pharmacol
345:
309-314,
1998[Web of Science][Medline].
108.
Kidd, JF,
and
Thorn P.
Intracellular Ca2+ and Cl
channel activation in secretory cells.
Annu Rev Physiol
62:
493-513,
2000[Web of Science][Medline].
109.
Kim, E,
Niethammer M,
Rothschild A,
Jan YN,
and
Sheng M.
Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases.
Nature
378:
85-88,
1995[Medline].
110.
Kirk, KL.
New paradigms of CFTR chloride channel regulation.
Cell Mol Life Sci
57:
623-634,
2000[Web of Science][Medline].
111.
Koch, WJ,
Ellinor PT,
and
Schwartz A.
cDNA cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms.
J Biol Chem
265:
17786-17791,
1990
112.
Köhr, G,
and
Seeburg PH.
Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family.
J Physiol (Lond)
492:
445-452,
1996
113.
Kusaka, M,
and
Sperelakis N.
Inhibition of L-type calcium current by genistein, a tyrosine kinase inhibitor, in pregnant rat myometrial cells.
Biochim Biophys Acta
1240:
196-200,
1995[Medline].
114.
Kusaka, M,
and
Sperelakis N.
Genistein inhibition of fast Na+ current in uterine leiomyosarcoma cells is independent of tyrosine kinase inhibition.
Biochim Biophys Acta
1278:
1-4,
1996[Medline].
115.
Lau, LF,
and
Huganir RL.
Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits.
J Biol Chem
270:
20036-20041,
1995
116.
Lee, KM,
Toscas K,
and
Villereal ML.
Inhibition of bradykinin- and thapsigargin-induced Ca2+ entry by tyrosine kinase inhibitors.
J Biol Chem
268:
9945-9948,
1993
117.
Lemmon, MA,
and
Schlessinger J.
Regulation of signal transduction and signal diversity by receptor oligomerization.
Trends Biochem Sci
19:
459-463,
1994[Web of Science][Medline].
118.
Lepple-Wienhues, A,
Szabó I,
Laun T,
Kaba NK,
Gulbins E,
and
Lang F.
The tyrosine kinase p56lck mediates activation of swelling-induced chloride channels in lymphocytes.
J Cell Biol
141:
281-286,
1998
119.
Lepple-Wienhues, A,
Szabo I,
Wieland U,
Heil L,
Gulbins E,
and
Lang F.
Tyrosine kinases open lymphocyte chloride channels.
Cell Physiol Biochem
10:
307-312,
2000[Web of Science][Medline].
120.
Lesser, SS,
and
Lo DC.
Regulation of voltage-gated ion channels by NGF and ciliary neurotrophic factor in SK-N-SH neuroblastoma cells.
J Neurosci
15:
253-261,
1995[Abstract].
121.
Leung, YM,
and
Kwan CY.
Current perspectives in the pharmacological studies of store-operated Ca2+ entry blockers.
Jpn J Pharmacol
81:
253-258,
1999[Medline].
122.
Lev, S,
Moreno H,
Martinez R,
Canoll P,
Peles E,
Musacchio JM,
Plowman GD,
Rudy B,
and
Schlessinger J.
Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions.
Nature
376:
737-745,
1995[Medline].
123.
Levitan, IB.
Modulation of ion channels by protein phosphorylation and dephosphorylation.
Annu Rev Physiol
56:
193-212,
1994[Web of Science][Medline].
124.
Levitan, IB.
Modulation of ion channels by protein phosphorylation-how the brain works.
Adv Second Messenger Phosphoprotein Res
33:
3-22,
1999[Web of Science][Medline].
125.
Ling, S,
Woronuk G,
Sy L,
Lev S,
and
Braun AP.
Enhanced activity of a large conductance, calcium-sensitive K+ channel in the presence of Src tyrosine kinase.
J Biol Chem
275:
30683-30689,
2000
126.
Liu, H,
Li K,
and
Sperelakis N.
Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells.
Can J Physiol Pharmacol
75:
1058-1062,
1997[Web of Science][Medline].
127.
Liu, H,
and
Sperelakis N.
Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.
Can J Physiol Pharmacol
75:
1063-1068,
1997[Web of Science][Medline].
128.
Ma, H,
Matsunaga H,
Li B,
Marrero MB,
and
Ling BN.
Regulation of PDGF-
receptor-operated Ca2+ channels by phospholipase C
-1 in glomerular mesangial cells.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F994-F1003,
1996
129.
Ma, H,
Matsunaga H,
Li B,
Schieffer B,
Marrero MB,
and
Ling BN.
Ca2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells.
J Clin Invest
97:
2332-2341,
1996[Web of Science][Medline].
130.
Ma, HT,
Patterson RL,
Van Rossum DB,
Birnbaumer L,
Mikoshiba K,
and
Gill DL.
Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels.
Science
287:
1647-1651,
2000
131.
Macfarlane, SN,
and
Sontheimer H.
Modulation of Kv1.5 currents by Src tyrosine phosphorylation: potential role in the differentiation of astrocytes.
J Neurosci
20:
5245-5253,
2000
132.
Marrero, MB,
Schieffer B,
Bernstein KE,
and
Ling BN.
Angiotensin II-induced tyrosine phosphorylation in mesangial and vascular smooth muscle cells.
Clin Exp Pharmacol Physiol
23:
83-88,
1996[Web of Science][Medline].
133.
Marrero, MB,
Schieffer B,
Ma H,
Bernstein KE,
and
Ling BN.
ANG II-induced tyrosine phosphorylation stimulates phospholipase C-
1 and Cl
channels in mesangial cells.
Am J Physiol Cell Physiol
270:
C1834-C1842,
1996
134.
Marunaka, Y,
Niisato N,
O'Brodovich H,
Post M,
and
Tanswell AK.
Roles of Ca2+ and protein tyrosine kinase in insulin action on cell volume via Na+ and K+ channels and Na+/K+/2Cl
cotransporter in fetal rat alveolar type II pneumocyte.
J Membr Biol
168:
91-101,
1999[Web of Science][Medline].
135.
Masumoto, N,
Nakayama K,
Oyabe A,
Uchino M,
Ishii K,
Obara K,
and
Tanabe Y.
Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.
Eur J Pharmacol
330:
55-63,
1997[Web of Science][Medline].
136.
Matsumoto, PS,
Ohara A,
Duchatelle P,
and
Eaton DC.
Tyrosine kinase regulates epithelial sodium transport in A6 cells.
Am J Physiol Cell Physiol
264:
C246-C250,
1993
137.
Maximov, A,
Sudhof TC,
and
Bezprozvanny I.
Association of neuronal calcium channels with modular adaptor proteins.
J Biol Chem
274:
24453-24456,
1999
138.
Mays, DJ,
Foose JM,
Philipson LH,
and
Tamkun MM.
Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.
J Clin Invest
96:
282-292,
1995.
139.
Mcdonald, FJ,
and
Welsh MJ.
Binding of the proline-rich region of the epithelial Na+ channel to SH3 domains and its association with specific cellular proteins.
Biochem J
312:
491-497,
1995.
140.
Mcdonald, TF,
Pelzer S,
Trautwein W,
and
Pelzer DJ.
Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells.
Physiol Rev
74:
365-507,
1994
141.
McHugh, D,
Sharp EM,
Scheuer T,
and
Catterall WA.
Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain.
Proc Natl Acad Sci USA
97:
12334-12338,
2000
142.
Mergler, S,
Steinhausen K,
Wiederholt M,
and
Strauss O.
Altered regulation of L-type channels by protein kinase C and protein tyrosine kinases as a pathophysiologic effect in retinal degeneration.
FASEB J
12:
1125-1134,
1998
143.
Meucci, O,
Scorziello A,
Avallone A,
Florio T,
D'alto V,
Fattore M,
and
Schettini G.
1B, But not
1A, adrenoreceptor activates calcium influx through the stimulation of a tyrosine kinase/phosphotyrosine phosphatase pathway, following noradrenaline-induced emptying of IP3 sensitive calcium stores, in PC Cl3 rat thyroid cell line.
Biochem Biophys Res Commun
209:
630-638,
1995[Web of Science][Medline].
144.
Meza, U,
Bannister R,
Melliti K,
and
Adams B.
Biphasic, opposing modulation of cloned neuronal
1E Ca channels by distinct signaling pathways coupled to M2 muscarinic acetylcholine receptors.
J Neurosci
19:
6806-6817,
1999
145.
Minami, K,
Fukuzawa K,
and
Inoue I.
Regulation of a non-selective cation channel of cultured porcine coronary artery smooth muscle cells by tyrosine kinase.
Pflügers Arch
426:
254-257,
1994[Web of Science][Medline].
146.
Miyamoto, S,
Akiyama SK,
and
Yamada KM.
Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function.
Science
267:
883-885,
1995
147.
Molokanova, E,
Maddox F,
Luetje CW,
and
Kramer RH.
Activity-dependent modulation of rod photoreceptor cyclic nucleotide-gated channels mediated by phosphorylation of a specific tyrosine residue.
J Neurosci
19:
4786-4795,
1999
148.
Molokanova, E,
Trivedi B,
Savchenko A,
and
Kramer RH.
Modulation of rod photoreceptor cyclic nucleotide-gated channels by tyrosine phosphorylation.
J Neurosci
17:
9068-9076,
1997
149.
Montell, C.
Visual transduction in Drosophila.
Annu Rev Cell Dev Biol
15:
231-268,
1999[Web of Science][Medline].
150.
Montell, C,
and
Rubin GM.
Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction.
Neuron
2:
1313-1323,
1989[Web of Science][Medline].
151.
Moon, IS,
Apperson ML,
and
Kennedy MB.
The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B.
Proc Natl Acad Sci USA
91:
3954-3958,
1994
152.
Mori, Y,
Okada T,
and
Shimizu S.
Receptor-activated Ca2+ influx: capacitative Ca2+ entry and TRP proteins.
Nippon Yakurigaku Zasshi
114:
149-160,
1999[Medline].
153.
Morikawa, H,
Fukuda K,
Mima H,
Shoda T,
Kato S,
and
Mori K.
Tyrosine kinase inhibitors suppress N-type and T-type Ca2+ channel currents in NG108-15 cells.
Pflügers Arch
436:
127-132,
1998[Web of Science][Medline].
154.
Moss, SJ,
Gorrie GH,
Amato A,
and
Smart TG.
Modulation of GABAA receptors by tyrosine phosphorylation.
Nature
377:
344-348,
1995[Medline].
155.
Naren, AP,
Nelson DJ,
Xie W,
Jovov B,
Pevsner J,
Bennett MK,
Benos DJ,
Quick MW,
and
Kirk KL.
Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms.
Nature
390:
302-305,
1997[Medline].
156.
Nehring, RB,
Wischmeyer E,
Doring F,
Veh RW,
Sheng M,
and
Karschin A.
Neuronal inwardly rectifying K+ channels differentially couple to PDZ proteins of the PSD-95/SAP90 family.
J Neurosci
20:
156-162,
2000
157.
Nelson, MT,
and
Quayle JM.
Physiological roles and properties of potassium channels in arterial smooth muscle.
Am J Physiol Cell Physiol
268:
C799-C822,
1995
158.
Niisato, N,
Ito Y,
and
Marunaka Y.
Activation of Cl
channel and Na+/K+/2Cl
cotransporter in renal epithelial A6 cells by flavonoids: genistein, daidzein, and apigenin.
Biochem Biophys Res Commun
254:
368-371,
1999[Web of Science][Medline].
159.
Niisato, N,
Van Driessche W,
Liu M,
and
Marunaka Y.
Involvement of protein tyrosine kinase in osmoregulation of Na+ transport and membrane capacitance in renal A6 cells.
J Membr Biol
175:
63-77,
2000[Web of Science][Medline].
160.
Niklinska, BB,
Yamada H,
O'Shea JJ,
June CH,
and
Ashwell JD.
Tyrosine kinase-regulated and inositol phosphate-independent Ca2+ elevation and mobilization in T cells.
J Biol Chem
267:
7154-7159,
1992
161.
Nishio, M,
Habuchi Y,
Tanaka H,
Morikawa J,
Okanoue T,
and
Kashima K.
Tyrosine kinase-dependent modulation by interferon-
of the ATP-sensitive K+ current in rabbit ventricular myocytes.
FEBS Lett
445:
87-91,
1999[Web of Science][Medline].
162.
Ogura, T,
Shuba LM,
and
Mcdonald TF.
L-type Ca2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation.
Am J Physiol Heart Circ Physiol
276:
H1724-H1733,
1999
163.
Ohta, T,
Yasuda W,
Hasegawa A,
Ito S,
and
Nakazato Y.
Effects of inhibitors for tyrosine kinase and non-selective cation channel on capacitative Ca2+ entry in rat ileal smooth muscle.
Eur J Pharmacol
387:
211-220,
2000[Web of Science][Medline].
164.
Okada, M,
and
Nakagawa H.
A protein tyrosine kinase involved in regulation of pp60c-src function.
J Biol Chem
264:
20886-20893,
1989
165.
Osol, G,
Laher I,
and
Kelley M.
Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries.
Am J Physiol Heart Circ Physiol
265:
H415-H420,
1993
166.
Paillart, C,
Carlier E,
Guedin D,
Dargent B,
and
Couraud F.
Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor.
J Pharmacol Exp Ther
280:
521-526,
1997
167.
Parekh, AB,
and
Penner R.
Store depletion and calcium influx.
Physiol Rev
77:
901-930,
1997
168.
Parekh, AB,
Terlau H,
and
Stühmer W.
Depletion of InsP3 stores activates a Ca2+ and K+ current by means of a phosphatase and a diffusible messenger.
Nature
364:
814-818,
1993[Medline].
169.
Patterson, RL,
Van Rossum DB,
and
Gill DL.
Store-operated Ca2+ entry: evidence for a secretion-like coupling model.
Cell
98:
487-499,
1999[Web of Science][Medline].
170.
Pawson, T,
and
Scott JD.
Signaling through scaffold, anchoring, and adaptor proteins.
Science
278:
2075-2080,
1997
171.
Pearson, RB,
and
Kemp BE.
Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations.
Methods Enzymol
200:
62-81,
1991[Web of Science][Medline].
172.
Peppelenbosch, MP,
Tertoolen LG,
and
De Laat SW.
Epidermal growth factor-activated calcium and potassium channels.
J Biol Chem
266:
19938-19944,
1991
173.
Peretz, A,
Sobko A,
and
Attali B.
Tyrosine kinases modulate K+ channel gating in mouse Schwann cells.
J Physiol (Lond)
519:
373-384,
1999
174.
Petrone, A,
and
Sap J.
Emerging issues in receptor protein tyrosine phosphatase function: lifting fog or simply shifting?
J Cell Sci
113:
2345-2354,
2000[Abstract].
175.
Pfeiffer, F,
Schmid A,
and
Schulz I.
Capacitative Ca2+ influx and a Ca2+ dependent nonselective cation pathway are discriminated by genistein in mouse pancreatic acinar cells.
Pflügers Arch
430:
916-922,
1995[Web of Science][Medline].
176.
Philipp, S,
Trost C,
Warnat J,
Rautmann J,
Himmerkus N,
Schroth G,
Kretz O,
Nastainczyk W,
Cavalie A,
Hoth M,
and
Flockerzi V.
TRP4 (CCE1) protein is part of native calcium release-activated Ca2+-like channels in adrenal cells.
J Biol Chem
275:
23965-23972,
2000
177.
Picciotto, MR,
Cohn JA,
Bertuzzi G,
Greengard P,
and
Nairn AC.
Phosphorylation of the cystic fibrosis transmembrane conductance regulator.
J Biol Chem
267:
12742-12752,
1992
178.
Pollock, JD,
Krempin M,
and
Rudy B.
Differential effects of NGF, FGF, EGF, cAMP, and dexamethasone on neurite outgrowth and sodium channel expression in PC12 cells.
J Neurosci
10:
2626-2637,
1990[Abstract].
179.
Polte, TR,
and
Hanks SK.
Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130Cas) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs.
J Biol Chem
272:
5501-5509,
1997
180.
Ponting, CP,
Phillips C,
Davies KE,
and
Blake DJ.
PDZ domains: targeting signalling molecules to sub-membranous sites.
Bioessays
19:
469-479,
1997[Web of Science][Medline].
181.
Prevarskaya, NB,
Skryma RN,
Vacher P,
Daniel N,
Djiane J,
and
Dufy B.
Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase.
J Biol Chem
270:
24292-24299,
1995
182.
Putney, JW, Jr.
A model for receptor-regulated calcium entry.
Cell Calcium
7:
1-12,
1986[Web of Science][Medline].
183.
Qin, N,
Platano D,
Olcese R,
Stefani E,
and
Birnbaumer L.
Direct interaction of G
with a C-terminal G
-binding domain of the Ca2+ channel
1 subunit is responsible for channel inhibition by G protein-coupled receptors.
Proc Natl Acad Sci USA
94:
8866-8871,
1997
184.
Qu, Y,
Rogers J,
Tanada T,
Scheuer T,
and
Catterall WA.
Modulation of cardiac Na+ channels expressed in a mammalian cell line and in ventricular myocytes by protein kinase C.
Proc Natl Acad Sci USA
91:
3289-3293,
1994
185.
Rane, SG,
and
Pollock JD.
Fibroblast growth factor-induced increases in calcium currents in the PC12 pheochromocytoma cell line are tyrosine phosphorylation dependent.
J Neurosci Res
38:
590-598,
1994[Web of Science][Medline].
186.
Ranganathan, R,
and
Ross EM.
PDZ domain proteins: scaffolds for signaling complexes.
Curr Biol
7:
R770-R773,
1997[Web of Science][Medline].
187.
Ratcliffe, CF,
Qu Y,
McCormick KA,
Tibbs VC,
Dixon JE,
Scheuer T,
and
Catterall WA.
A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase
.
Nature Neurosci
3:
437-444,
2000[Web of Science][Medline].
188.
Ricard, J,
Giudici-Orticoni MT,
and
Gontero B.
The modulation of enzyme reaction rates within multi-enzyme complexes. I. Statistical thermodynamics of information transfer through multi-enzyme complexes.
Eur J Biochem
226:
993-998,
1994[Web of Science][Medline].
189.
Rogalski, SL,
Appleyard SM,
Pattillo A,
Terman GW,
and
Chavkin C.
TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel.
J Biol Chem
275:
25082-25088,
2000
190.
Rosado, JA,
Jenner S,
and
Sage SO.
A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets. Evidence for conformational coupling.
J Biol Chem
275:
7527-7533,
2000
191.
Rosenblum, K,
Dudai Y,
and
Richter-Levin G.
Long-term potentiation increases tyrosine phosphorylation of the N- methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo.
Proc Natl Acad Sci USA
93:
10457-10460,
1996
192.
Rostas, JA,
Brent VA,
Voss K,
Errington ML,
Bliss TV,
and
Gurd JW.
Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation.
Proc Natl Acad Sci USA
93:
10452-10456,
1996
193.
Runnels, LW,
Yue L,
and
Clapham DE.
TRP-PLIK, a bifunctional protein with kinase and ion channel activities.
Science
291:
1043-1047,
2001
194.
Ruppersberg, JP.
Intracellular regulation of inward rectifier K+ channels.
Pflügers Arch
441:
1-11,
2000[Web of Science][Medline].
195.
Sap, J,
D'eustachio P,
Givol D,
and
Schlessinger J.
Cloning and expression of a widely expressed receptor tyrosine phosphatase.
Proc Natl Acad Sci USA
87:
6112-6116,
1990
196.
Sargeant, P,
Farndale RW,
and
Sage SO.
ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets.
J Biol Chem
268:
18151-18156,
1993
197.
Sargeant, P,
Farndale RW,
and
Sage SO.
The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets.
FEBS Lett
315:
242-246,
1993[Web of Science][Medline].
198.
Schaller, MD,
Hildebrand JD,
Shannon JD,
Fox JW,
Vines RR,
and
Parsons JT.
Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2- dependent binding of pp60src.
Mol Cell Biol
14:
1680-1688,
1994
199.
Schindelholz, B,
and
Reber BFX
L-type Ca2+ channels and purinergic P2X2 cation channels participate in calcium-tyrosine kinase-mediated PC12 growth cone arrest.
Eur J Neurosci
12:
194-204,
2000[Web of Science][Medline].
200.
Schlaepfer, DD,
Hanks SK,
Hunter T,
and
Van Der Geer P.
Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase.
Nature
372:
786-791,
1994[Medline].
201.
Schlaepfer, DD,
Hauck CR,
and
Sieg DJ.
Signaling through focal adhesion kinase.
Prog Biophys Mol Biol
71:
435-478,
1999[Web of Science][Medline].
202.
Schwartz, MA,
and
Denninghoff K.
v Integrins mediate the rise in intracellular calcium in endothelial cells on fibronectin even though they play a minor role in adhesion.
J Biol Chem
269:
11133-11137,
1994
203.
Schwartz, MA,
Schaller MD,
and
Ginsberg MH.
Integrins: emerging paradigms of signal transduction.
Annu Rev Cell Dev Biol
11:
549-599,
1995[Web of Science][Medline].
204.
Selinfreund, RH,
and
Blair LA.
Insulin-like growth factor-I induces a rapid increase in calcium currents and spontaneous membrane activity in clonal pituitary cells.
Mol Pharmacol
45:
1215-1220,
1994[Abstract].
205.
Sharma, NR,
and
Davis MJ.
Substance P-induced calcium entry in endothelial cells is secondary to depletion of intracellular stores.
Am J Physiol Heart Circ Physiol
268:
H962-H973,
1995
206.
Sharma, NR,
and
Davis MJ.
Calcium entry activated by store depletion in coronary endothelium is promoted by tyrosine phosphorylation.
Am J Physiol Heart Circ Physiol
270:
H267-H274,
1996
207.
Sheng, M,
and
Pak DT.
Ligand-gated ion channel interactions with cytoskeletal and signaling proteins.
Annu Rev Physiol
62:
755-778,
2000[Web of Science][Medline].
208.
Sheng, M,
and
Wyszynski M.
Ion channel targeting in neurons.
Bioessays
19:
847-853,
1997[Web of Science][Medline].
209.
Sheng, ZH,
Rettig J,
Cook T,
and
Catterall WA.
Calcium-dependent interaction of N-type calcium channels with the synaptic core complex.
Nature
379:
451-454,
1996[Medline].
210.
Sheng, ZH,
Rettig J,
Takahashi M,
and
Catterall WA.
Identification of a syntaxin-binding site on N-type calcium channels.
Neuron
13:
1303-1313,
1994[Web of Science][Medline].
211.
Sheppard, DN,
and
Welsh MJ.
Structure and function of the CFTR chloride channel.
Physiol Rev
79:
S23-S45,
1999.
212.
Shistik, E,
Keren-Raifman T,
Idelson GH,
Blumenstein Y,
Dascal N,
and
Ivanina T.
The N terminus of the cardiac L-type Ca2+ channel
1C subunit-the initial segment is ubiquitous and crucial for protein kinase C modulation, but is not directly phosphorylated.
J Biol Chem
274:
31145-31149,
1999
213.
Shuba, LM,
and
Mcdonald TF.
Synergistic activation of guinea-pig cardiac cystic fibrosis transmembrane conductance regulator by the tyrosine kinase inhibitor genistein and cAMP.
J Physiol (Lond)
505:
23-40,
1997
214.
Shuba, YM,
Prevarskaya N,
Lemonnier L,
Van Coppenolle F,
Kostyuk PG,
Mauroy B,
and
Skryma R.
Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line.
Am J Physiol Cell Physiol
279:
C1144-C1154,
2000
215.
Siegelbaum, SA.
Channel regulation: ion channel control by tyrosine phosphorylation.
Curr Biol
4:
242-245,
1994[Web of Science][Medline].
216.
Smirnov, SV,
and
Aaronson PI.
Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638.
Circ Res
76:
310-316,
1995
217.
Smith, RD,
and
Goldin AL.
Protein kinase A phosphorylation enhances sodium channel currents in Xenopus oocytes.
Am J Physiol Cell Physiol
263:
C660-C666,
1992
218.
Snyder, PM,
Cheng C,
Prince LS,
Rogers JC,
and
Welsh MJ.
Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits.
J Biol Chem
273:
681-684,
1998
219.
Sobko, A,
Peretz A,
and
Attali B.
Constitutive activation of delayed-rectifier potassium channels by a Src family tyrosine kinase in Schwann cells.
EMBO J
17:
4723-4734,
1998[Web of Science][Medline].
220.
Songyang, Z,
Carraway KL,
Iii Eck MJ,
Harrison SC,
Feldman RA,
Mohammadi M,
Schlessinger J,
Hubbard SR,
Smith DP,
Eng C,
Lorenzo MJ,
Ponder BAJ,
Mayer BJ,
and
Cantley LC.
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling.
Nature
373:
536-539,
1995[Medline].
221.
Sorota, S.
Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current.
Pflügers Arch
431:
178-185,
1995[Web of Science][Medline].
222.
Strauss, O,
Buss F,
Rosenthal R,
Fischer D,
Mergler S,
Stumpff F,
and
Thieme H.
Activation of neuroendocrine L-type channels (
1D subunits) in retinal pigment epithelial cells and brain neurons by pp60c-src.
Biochem Biophys Res Commun
270:
806-810,
2000[Web of Science][Medline].
223.
Strauss, O,
Mergler S,
and
Wiederholt M.
Regulation of L-type calcium channels by protein tyrosine kinase and protein kinase C in cultured rat and human retinal pigment epithelial cells.
FASEB J
11:
859-867,
1997[Abstract].
224.
Striessnig, J.
Pharmacology, structure and function of cardiac L-type Ca2+ channels.
Cell Physiol Biochem
9:
242-269,
1999[Web of Science][Medline].
225.
Sun, F,
Hug MJ,
Bradbury NA,
and
Frizzell RA.
Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin.
J Biol Chem
275:
14360-14366,
2000
226.
Suzuki, A,
Kozawa O,
Saito H,
and
Oiso Y.
Effect of prostaglandin F2 alpha on Ca2+ influx in osteoblast-like cells: function of tyrosine kinase.
J Cell Biochem
54:
487-493,
1994[Web of Science][Medline].
227.
Swope, SL,
and
Huganir RL.
Molecular cloning of two abundant protein tyrosine kinases in Torpedo electric organ that associate with the acetylcholine receptor.
J Biol Chem
268:
25152-25161,
1993
228.
Swope, SL,
and
Huganir RL.
Binding of the nicotinic acetylcholine receptor to SH2 domains of Fyn and Fyk protein tyrosine kinases.
J Biol Chem
269:
29817-29824,
1994
229.
Szabo, I,
Gulbins E,
Apfel H,
Zhang X,
Barth P,
Busch AE,
Schlottmann K,
Pongs O,
and
Lang F.
Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation.
J Biol Chem
34:
20465-20469,
1996.
230.
Szücs, G,
Heinke S,
Degreef C,
Raeymaekers L,
Eggermont J,
Droogmans G,
and
Nilius B.
The volume-activated chloride current in endothelial cells from bovine pulmonary artery is not modulated by phosphorylation.
Pflügers Arch
431:
540-548,
1996[Web of Science][Medline].
231.
Takeuchi, T,
Kishi M,
Hirayama N,
Yamaji M,
Ishii T,
Nishio H,
Hata F,
and
Takewaki T.
Tyrosine kinase involvement in apamin-sensitive inhibitory responses of rat distal colon.
J Physiol (Lond)
514:
177-188,
1999
232.
Tezuka, T,
Umemori H,
Akiyama T,
Nakanishi S,
and
Yamamoto T.
PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.
Proc Natl Acad Sci USA
96:
435-440,
1999
233.
Thomas, SM,
and
Brugge JS.
Cellular functions regulated by Src family kinases.
Annu Rev Cell Dev Biol
13:
513-609,
1997[Web of Science][Medline].
234.
Tilly, BC,
Van Den Berghe N,
Tertoolen LG,
Edixhoven MJ,
and
De Jonge HR.
Protein tyrosine phosphorylation is involved in osmoregulation of ionic conductances.
J Biol Chem
268:
19919-19922,
1993
235.
Timpe, LC,
and
Fantl WJ.
Modulation of a voltage-activated potassium channel by peptide growth factor receptors.
J Neurosci
14:
1195-1201,
1994[Abstract].
236.
Toma, C,
Jensen PE,
Prieto D,
Hughes A,
Mulvany MJ,
and
Aalkjæer C.
Effects of tyrosine kinase inhibitors on the contractility of rat mesenteric resistance arteries.
Br J Pharmacol
114:
1266-1272,
1995[Web of Science][Medline].
237.
Toro, L,
Wallner M,
Meera P,
and
Tanaka Y.
Maxi-KCa, a unique member of the voltage-gated K+ channel superfamily.
News Physiol Sci
13:
112-117,
1998
238.
Tsai, W,
Morielli AD,
Cachero TG,
and
Peralta EG.
Receptor protein tyrosine phosphatase
participates in the M1 muscarinic acetylcholine receptor-dependent regulation of Kv1.2 channel activity.
EMBO J
18:
109-118,
1999[Web of Science][Medline].
239.
Tsai, W,
Morielli AD,
and
Peralta EG.
The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity.
EMBO J
16:
4597-4605,
1997[Web of Science][Medline].
240.
Tsunoda, Y.
Receptor-operated calcium influx mediated by protein tyrosine kinase pathways.
J Recept Signal Transduct Res
18:
281-310,
1998[Web of Science][Medline].
241.
Tsunoda, Y,
Yoshida H,
Africa L,
Steil GJ,
and
Owyang C.
Src kinase pathways in extracellular Ca2+-dependent pancreatic enzyme secretion.
Biochem Biophys Res Commun
227:
876-884,
1996[Web of Science][Medline].
242.
Vaca, L,
and
Kunze DL.
Depletion of intracellular Ca2+ stores activates a Ca2+-selective channel in vascular endothelium.
Am J Physiol Cell Physiol
267:
C920-C925,
1994
243.
Valenzuela, CF,
Machu TK,
McKernan RM,
Whiting P,
VanRenterghem BB,
McManaman JL,
Brozowski SJ,
Smith GB,
Olsen RW,
and
Harris RA.
Tyrosine kinase phosphorylation of GABAA receptors.
Brain Res Mol Brain Res
31:
165-172,
1995[Medline].
244.
Valverde, MA.
CIC channels: leaving the dark ages on the verge of a new millennium.
Curr Opin Cell Biol
11:
509-516,
1999[Web of Science][Medline].
245.
Voets, T,
Manolopoulos V,
Eggermont J,
Ellory C,
Droogmans G,
and
Nilius B.
Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins.
J Physiol (Lond)
506:
341-352,
1998
246.
Vostal, JG,
Jackson WL,
and
Shulman NR.
Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins.
J Biol Chem
266:
16911-16916,
1991
247.
Vuori, K.
Integrin signaling: tyrosine phosphorylation events in focal adhesions.
J Membr Biol
165:
191-199,
1998[Web of Science][Medline].
248.
Waitkus, KR,
Davis GE,
and
Meininger GA.
Collagen proteolysis and vasodilation in isolated rat cremaster arterioles (Abstract).
FASEB J
12:
A384,
1998.
249.
Walton, KM,
and
Dixon JE.
Protein tyrosine phosphatases.
Annu Rev Biochem
62:
101-120,
1993[Web of Science][Medline].
250.
Wan, Q,
Man HY,
Braunton J,
Wang W,
Salter MW,
Becker L,
and
Wang YT.
Modulation of GABAA receptor function by tyrosine phosphorylation of
subunits.
J Neurosci
17:
5062-5069,
1997
251.
Wang, W.
Regulation of the ROMK channel: interaction of the ROMK with associate proteins.
Am J Physiol Renal Physiol
277:
F826-F831,
1999
252.
Wang, YG,
and
Lipsius SL.
Genistein elicits biphasic effects on L-type Ca2+ current in feline atrial myocytes.
Am J Physiol Heart Circ Physiol
275:
H204-H212,
1998
253.
Wang, YT,
and
Salter MW.
Regulation of NMDA receptors by tyrosine kinases and phosphatases.
Nature
369:
233-235,
1994[Medline].
254.
Wang, YT,
Yu XM,
and
Salter MW.
Ca2+-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase.
Proc Natl Acad Sci USA
93:
1721-1725,
1996
255.
Wang, Z,
Estacion M,
and
Mordan LJ.
Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts.
Am J Physiol Cell Physiol
265:
C1239-C1246,
1993
256.
Wang, ZW,
and
Kotlikoff MI.
Activation of KCa channels in airway smooth muscle cells by endogenous protein kinase A.
Am J Physiol Lung Cell Mol Physiol
271:
L100-L105,
1996
257.
Watson, CL,
and
Gold MR.
Lysophosphatidylcholine modulates cardiac INa via multiple protein kinase pathways.
Circ Res
81:
387-395,
1997
258.
Wei, X,
Neely A,
Lacerda AE,
Olcese R,
Stefani E,
Perez-Reyes E,
and
Birnbaumer L.
Modification of Ca2+ channel activity by deletions at the carboxyl terminus of the cardiac alpha 1 subunit.
J Biol Chem
269:
1635-1640,
1994
259.
Wes, PD,
Chevesich J,
Jeromin A,
Rosenberg C,
Stetten G,
and
Montell C.
TRPC1, a human homolog of a Drosophila store-operated channel.
Proc Natl Acad Sci USA
92:
9652-9656,
1995
260.
Wijetunge, S,
Aalkjaer C,
Schachter M,
and
Hughes AD.
Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells.
Biochem Biophys Res Commun
189:
1620-1623,
1992[Web of Science][Medline].
261.
Wijetunge, S,
and
Hughes AD.
Effect of platelet-derived growth factor on voltage-operated calcium channels in rabbit isolated ear artery cells.
Br J Pharmacol
115:
534-538,
1995[Web of Science][Medline].
262.
Wijetunge, S,
and
Hughes AD.
pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells.
Biochem Biophys Res Commun
217:
1039-1044,
1995[Web of Science][Medline].
263.
Wijetunge, S,
and
Hughes AD.
Activation of endogenous c-Src or a related tyrosine kinase by intracellular (pY)EEI peptide increases voltage-operated calcium channel currents in rabbit ear artery cells.
FEBS Lett
399:
63-66,
1996[Web of Science][Medline].
264.
Wijetunge, S,
Lymn JS,
and
Hughes AD.
Effect of inhibition of tyrosine phosphatases on voltage-operated calcium channel currents in rabbit isolated ear artery cells.
Br J Pharmacol
124:
307-316,
1998[Web of Science][Medline].
265.
Wijetunge, S,
Lymn JS,
and
Hughes AD.
Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60c-src kinase activity.
Br J Pharmacol
129:
1347-1354,
2000[Web of Science][Medline].
266.
Wildering, WC,
Lodder JC,
Kits KS,
and
Bulloch AG.
Nerve growth factor (NGF) acutely enhances high-voltage-activated calcium currents in molluscan neurons.
J Neurophysiol
74:
2778-2781,
1995
267.
Wilson, GF,
and
Kaczmarek LK.
Mode-switching of a voltage-gated cation channel is mediated by a protein kinase A-regulated tyrosine phosphatase.
Nature
366:
433-438,
1993[Medline].
268.
Wischmeyer, E,
Doring F,
and
Karschin A.
Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation.
J Biol Chem
273:
34063-34068,
1998
269.
Wiser, O,
Trus M,
Hernandez A,
Renstrom E,
Barg S,
Rorsman P,
and
Atlas D.
The voltage sensitive L-type Ca2+ channel is functionally coupled to the exocytotic machinery.
Proc Natl Acad Sci USA
96:
248-253,
1999
270.
Wu X, Davis GE, Meininger GA, Wilson E, and Davis MJ. Regulation
of the L-type calcium channel by
5
1 integrin requires signaling
between focal adhesion proteins. J Biol Chem 29: 2001. In press.
271.
Wu, X,
Mogford JE,
Platts SH,
Davis GE,
Meininger GA,
and
Davis MJ.
Modulation of calcium current in arteriolar smooth muscle by
v
3 and
5
1 integrin ligands.
J Cell Biol
143:
241-252,
1998
272.
Wyszynski, M,
Lin J,
Rao A,
Nigh E,
Beggs AH,
Craig AM,
and
Sheng M.
Competitive binding of
-actinin and calmodulin to the NMDA receptor.
Nature
385:
439-442,
1997[Medline].
273.
Xu, XZ,
Choudhury A,
Li X,
and
Montell C.
Coordination of an array of signaling proteins through homo- and heteromeric interactions between PDZ domains and target proteins.
J Cell Biol
142:
545-555,
1998
274.
Yokoshiki, H,
Sumii K,
and
Sperelakis N.
Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein.
J Mol Cell Cardiol
28:
807-814,
1996[Web of Science][Medline].
275.
Yu, XM,
Askalan R,
Keil GJ, II,
and
Salter MW.
NMDA channel regulation by channel-associated protein tyrosine kinase Src.
Science
275:
674-678,
1997
276.
Yule, DI,
Kim ET,
and
Williams JA.
Tyrosine kinase inhibitors attenuate "capacitative" Ca2+ influx in rat pancreatic acinar cells.
Biochem Biophys Res Commun
202:
1697-1704,
1994[Web of Science][Medline].
277.
Zagotta, WN,
and
Siegelbaum SA.
Structure and function of cyclic nucleotide-gated channels.
Annu Rev Neurosci
19:
235-263,
1996[Web of Science][Medline].
278.
Zhang, ZH,
and
Wang Q.
Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
Pflügers Arch
440:
784-792,
2000[Web of Science][Medline].
279.
Zheng, X,
Zhang L,
Wang AP,
Bennett MV,
and
Zukin RS.
Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits.
Proc Natl Acad Sci USA
96:
15262-15267,
1999
280.
Zhou, WL,
Sugioka M,
Sakaki Y,
and
Yamashita M.
Regulation of capacitative Ca2+ entry by tyrosine phosphorylation in the neural retina of chick embryo.
Neurosci Lett
272:
123-126,
1999[Web of Science][Medline].
281.
Zitt, C,
Zobel A,
Obukhov AG,
Harteneck C,
Kalkbrenner F,
Luckhoff A,
and
Schultz G.
Cloning and functional expression of a human Ca2+-permeable cation channel activated by calcium store depletion.
Neuron
16:
1189-1196,
1996[Web of Science][Medline].
282.
Zuckerman, JB,
Chen X,
Jacobs JD,
Hu B,
Kleyman TR,
and
Smith PR.
Association of the epithelial sodium channel with Apx and
-spectrin in A6 renal epithelial cells.
J Biol Chem
274:
23286-23295,
1999
283.
Zweifach, A,
and
Lewis RS.
Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores.
Proc Natl Acad Sci USA
90:
6295-6299,
1993
This article has been cited by other articles:
![]() |
W. Chen and R. A. Khalil Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jeulin, V. Seltzer, D. Bailbe, K. Andreau, and F. Marano EGF mediates calcium-activated chloride channel activation in the human bronchial epithelial cell line 16HBE14o-: involvement of tyrosine kinase p60c-src Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L489 - L496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Sjostrom, E. A. Rancz, A. Roth, and M. Hausser Dendritic Excitability and Synaptic Plasticity Physiol Rev, April 1, 2008; 88(2): 769 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hinard, D. Belin, S. Konig, C. R. Bader, and L. Bernheim Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242 Development, March 1, 2008; 135(5): 859 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Li, Q. Zhang, B. Teng, S. J. Mustafa, J.-Y. Huang, and H.-G. Yu Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531 Am J Physiol Cell Physiol, January 1, 2008; 294(1): C355 - C362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kang, G. R. Ross, and H. I. Akbarali COOH-terminal association of human smooth muscle calcium channel Cav1.2b with Src kinase protein binding domains: effect of nitrotyrosylation Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1983 - C1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abriel Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies Cardiovasc Res, December 1, 2007; 76(3): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Zhou, L.-B. Zhang, W.-P. Sun, F.-C. Xiao, Y.-M. Zhou, Y.-J. Li, and D.-L. Li Heart/Cardiac Muscle: Effects of monocarboxylic acid-derived Cl- channel blockers on depolarization-activated potassium currents in rat ventricular myocytes Exp Physiol, May 1, 2007; 92(3): 549 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Missan, P. Linsdell, and T. F. McDonald Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes J. Physiol., June 1, 2006; 573(2): 469 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zong, C. Eckert, H. Yuan, C. Wahl-Schott, H. Abicht, L. Fang, R. Li, P. Mistrik, A. Gerstner, B. Much, et al. A Novel Mechanism of Modulation of Hyperpolarization-activated Cyclic Nucleotide-gated Channels by Src Kinase J. Biol. Chem., October 7, 2005; 280(40): 34224 - 34232. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chittajallu, A. A. Aguirre, and V. Gallo Downregulation of Platelet-Derived Growth Factor-{alpha} Receptor-Mediated Tyrosine Kinase Activity as a Cellular Mechanism for K+-Channel Regulation during Oligodendrocyte Development In Situ J. Neurosci., September 21, 2005; 25(38): 8601 - 8610. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Akbarali Signal-Transduction Pathways that Regulate Smooth Muscle Function II. Receptor-ion channel coupling mechanisms in gastrointestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G598 - G602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ling, J.-Z. Sheng, and A. P. Braun The calcium-dependent activity of large-conductance, calcium-activated K+ channels is enhanced by Pyk2- and Hck-induced tyrosine phosphorylation Am J Physiol Cell Physiol, September 1, 2004; 287(3): C698 - C706. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nesti, B. Everill, and A. D. Morielli Endocytosis as a Mechanism for Tyrosine Kinase-dependent Suppression of a Voltage-gated Potassium Channel Mol. Biol. Cell, September 1, 2004; 15(9): 4073 - 4088. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jin, N. Morsy, J. Winston, P. J. Pasricha, K. Garrett, and H. I. Akbarali Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase Am J Physiol Cell Physiol, August 1, 2004; 287(2): C558 - C563. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Bobkov and B. W. Ache Calcium Sensitivity of a Sodium-Activated Nonselective Cation Channel in Lobster Olfactory Receptor Neurons J Neurophysiol, November 1, 2003; 90(5): 2928 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Belevych, S. Warrier, and R. D. Harvey Genistein Inhibits Cardiac L-Type Ca2+ Channel Activity by a Tyrosine Kinase-Independent Mechanism Mol. Pharmacol., September 1, 2002; 62(3): 554 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Byron and P. A. Lucchesi Signal Transduction of Physiological Concentrations of Vasopressin in A7r5 Vascular Smooth Muscle Cells. A ROLE FOR PYK2 AND TYROSINE PHOSPHORYLATION OF K+ CHANNELS IN THE STIMULATION OF Ca2+ SPIKING J. Biol. Chem., February 22, 2002; 277(9): 7298 - 7307. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |